The Princess Margaret Hospital Foundation

Transcription

What’s in the Toolbox of a Top 5 Cancer Research Centre?
A Message from Dr. Mary Gospodarowicz and Dr. Ben Neel
The tools available to see cancer more clearly and treat it more effectively
have become more plentiful and more sophisticated. X-ray technology,
microscopes, scalpels, and single beam radiation machines have been superceded by MRI, computed tomography, laser capture microscopy, surgical
robots and shaped-beam radiation.
Learning how to leverage these tools and refine them for our specific purposes in cancer medicine has required that we expand our workforce in
certain areas. We now employ physicists, bioinformatics specialists, engineers
and medicinal chemists, as well as commercialization specialists who focus
solely on speeding new technology and discoveries into production so they
can help patients sooner.
There is a spirit of collaboration and a sense of urgency among our staff that
only a critical mission like conquering cancer in our lifetime can ignite. Here
are a few developments that illustrate the creativity of our scientists and
clinicians in the use of new tools and technology:
wThe
puzzle of why certain lung cancer patients responded well to chemotherapy in addition to surgery and others did not was solved by uncovering
a 3-gene ‘signature’ which was discovered and validated through sophisticated computer analysis of patient data from over 27 studies worldwide
wRobotic
equipment is being used to screen thousands of off-patent drugs
for their effectiveness against cancer cells. This ‘drug recycling’ approach
has identified several promising candidates, and it greatly shortens the
time by which a drug can be helping patients
wCancerous
tumours often spread to the bone, and this ‘infected’ bone
must be removed and ‘re-built’ using bone tissue harvested from another
part of the patient’s body. CT imaging is very effective for surgeons in
preparing for this re-constructive phase of the surgery
Our scientists have not only successfully adapted promising tools and
technology to cancer research and treatment, but they have created entirely
new tools.
We are highly dependent on our generous donors to maintain the high quality toolbox needed by our innovative
scientists, clinicians and surgeons. Thank you for appreciating this need for state-of-the-art tools. We feel confident
that we are making excellent use of the funds you entrust to us.
Dr. Mary Gospodarowicz, Medical Director
Cancer Program
Princess Margaret Hospital/UHN
Dr. Ben Neel, Research Director
Ontario Cancer Institute and
The Campbell Family Cancer Research Institute
Princess Margaret Hospital/UHN
In Our Lifetime
It may seem like we’ve been fighting this fight forever. But we haven’t.
There was a time, not long ago, when cancer was a death sentence. And the treatment
was dreaded almost as much as the disease. We’ve seen that change in our lifetime, at
The Princess Margaret.
We’ve seen the entire process of cancer care forever altered. We’ve seen radical mastectomies
become lumpectomies. We’ve seen the precision of image-guided therapies spare more healthy
tissue. We’ve seen undreamed-of advances at the cellular level and revolutionary work in healing
beyond the body.
All in our lifetime. All at The Princess Margaret.
We’ve seen a provincial cancer hospital become one of the world’s top 5 cancer research
centres. We’ve seen our people grow beyond a thousand. We’ve seen leading researchers, from all
over the world, leave their homes to come here. Because this is where they believe the fight will be
finished. In our lifetime.
Yes, we are still losing people to cancer. But imagine if Terry Fox were diagnosed today. He would
be much less likely to lose his leg and he could live to continue the fight. That’s how far we’ve
come, and that’s how fast.
It may seem like we’ll be fighting this fight forever. But we won’t. Because we’re closing in.
We have the momentum. We have the talent. And we have the passion. This is the front line. We
are Canada’s cancer warriors. But we can’t do it alone.
The world needs to hear The Princess Margaret message. So share it at every opportunity
with anyone who will listen.
It’s a simple message, really. But it’s a message of incredible power: we are conquering
cancer at Canada’s cancer research centre, The Princess Margaret. In our lifetime.
The Princess Margaret
1
‘Passion Capital’ Leads the Way to a Record Year
A Message from the President & CEO and the Chairman of the Foundation Board
Our heart leads us and drives us to support the causes we believe in. The passion that begins in our hearts and ignites
our spirit of generosity can accomplish amazing things. A new term for this collective spirit has emerged, and we believe
that ‘passion capital’ is what has enabled The Princess Margaret Hospital Foundation to raise over $73 million (net) for
It is obvious from meeting and speaking to many of you—annual donors, walkers, riders, lottery ticket buyers, and
event organizers—that conquering cancer is a cause that generates deep emotions and motivates people to dig
deeper and work harder to raise the funds needed for breakthrough research and compassionate care. We are very
grateful that you have continued your commitment to help CONQUER CANCER IN OUR LIFETIME this year.
We all want to leave a legacy to
our children of a world without
this disease, and that will require
that we continue to generously
invest our passion capital.
Our Major Gifts and Planned
Giving area raised just under
$28 million.
We are very thankful to the
Campbell Family for their
commitment of a $37.5 million
long-term gift that enabled us to
establish The Campbell Family
Cancer Research Institute. This
expanded facility houses all
of our basic science laboratories where top scientists and
researchers from around the
world are working as a team
to unravel and understand the
complexities of cancer.
Our appreciation also goes out to the Dr. Geoffrey R. Conway Memorial Foundation for its generous gift of
$6.5 million that will be used to create a new world-class chemotherapy centre now being constructed on the
fourth floor of the hospital and due to open to patients in late 2010.
The Gattuso-Slaight gift of $12.5 million to create The Gattuso Rapid Diagnostic Centre has generated a huge
groundswell of appreciation from the breast cancer community. This is a wonderful example of how our hospital is
always setting new standards of patient care.
Other highlights include:
w$1.3
million from Gordon Tozer in support of head and neck cancer research
w$1 million from Molly and David Bloom to establish the Molly and David Bloom Chair in Multiple Myeloma
Research, the first myeloma chair in Canada
2
2009 Report to Our Donors
wThe
campaign leading up to our Spotlight Tribute secured donations and commitments of over $700,000.
This year’s Tribute celebrated the world-leading efforts of The Robert and Maggie Bras and Family New Drug
Development Program in developing targeted and effective cancer therapies
w
$640,000 from AstraZeneca Canada Inc. to support lung cancer research and breast cancer research
One of the year’s greatest achievements for the Foundation was The Ride to Conquer Cancer—an event that is already
Canada’s most successful cycling fundraiser. Three years of careful planning and preparation paid off with 2,850 participants riding in the inaugural event and raising an incredible $14.8 million for cancer research. The Ride was so successful that 2009 will see the event run in three additional Canadian cities—Vancouver, Calgary and Montreal.
The Weekend to End Breast Cancer (WEBC) walkers got a little soggy this past year, but it seems that nothing can
dampen the spirits of 4,757 participants determined to bring an end to a horrible disease that has impacted their lives
in some way. They raised an amazing $13.5 million. This year we announced that funds from future WEBC events will
be directed to research projects focused on gynecological cancers in addition to breast cancer, plus there will now be
a one-day walk so more walkers can participate in this life changing event.
After conducting extensive market research with lottery ticket buyers, the Foundation re-vamped and re-launched
its fall lottery program. Branded the Welcome Home Sweepstakes, the lottery offered up an incredible selection
of real estate in a variety of prestigious locations. Lynda Reeves and her House & Home team lent their support by
designing and decorating the Oakville home. All of the prizes resonated well, as the lottery sold out in a tough
economic climate.
Our Community Giving team continues to engage and steward a growing base of more than 60,000 supporters
through our annual giving and tribute programs which raised a total of $6.3 million. We continued to build our
monthly giving program, and evolved our Leadership Giving Society into The Princess Margaret’s Inner Circle.
The Special Events team supported more than 100 community events last year, including galas, golf tournaments,
runs, walks, clothing sales, and more. The 2008 Brazilian Ball was a highlight of the year, raising the seed funding for
the de Souza Institute and for cancer research. More than 1,000 walkers raised $690,000 in the Toronto Marathon 5K;
Joe’s Team triathlon participants raised $470,000 for head and neck translational research; and Harry’s Spring Run-off
runners raised $336,000 for prostate cancer. In all, more than 30,000 Special Event supporters raised $5.2 million for
We were delighted to welcome Farsad Kiani to our Board this year. Mr. Kiani’s background and leadership in medical innovation and his extensive work with a wide variety of philanthropic organizations will be of great benefit to our
Foundation. The combined breadth and depth of expertise accessible to the Foundation through our Board members is a great source of strength and wisdom. An excellent example of that wisdom is the work of our Investment
Committee. Their counsel regarding the Foundation’s investment portfolio during a period of extreme capital market
turmoil allowed us to emerge from the storm in relatively good condition. Further information on our investment
portfolio is provided at the end of the Financials section of this report.
We hope you enjoy reading the stories in this report describing how the funds you donated or helped to raise are
being put to use by our dedicated doctors, scientists and other PMH staff. They are stories we would not be able to
tell without your support and your passion.
Paul Alofs
President & CEO
Keith P. Ambachtsheer
Chairman
3
Training our Body to Recognize and Destroy Tumour Cells
Harnessing the body’s immune system to fight cancer is an
intuitively appealing and tantalizing idea. An anti-cancer
vaccine is certainly the ‘holy grail’, and scientists at The
Princess Margaret have a collective understanding of the
human immune system that is getting us ever closer.
Dr. Tak Mak, Director of The Campbell Family Institute for
Breast Cancer Research at The Princess Margaret, is known
around the world as the first scientist to clone an important receptor found on white blood cells called T cells.
Identifying this receptor opened up the field of immunology because this structure is responsible for determining
the kind of foreign molecules that are the target of the
immune response. Together with his Co-Director,
Dr. Pamela Ohashi, he recently published scientific findings that showed the addition of interleukin-7 with a viral
vaccine boosted the body’s immunity to tumours.
The human immune system is an amazing defense system, always on guard to destroy foreign bacteria and viruses.
Even better, it can be further fortified to defend against life-threatening viruses that it may not recognize or have the
natural defenses to fight. Because of this we now have vaccinations against diseases such as small pox and tetanus.
Immunotherapy efforts are essentially organized along two fronts: development of vaccines to fight viruses that are
known to cause cancer (for example, human papillomavirus and hepatitis B and C), or identifying approaches to fire
up the immune system to fight an existing malignancy.
Because a tumour begins as a normal organ cell with a genetic aberration that allows it to grow and reproduce
without natural controls, the immune system does not see the tumour as ‘foreign’.
Dr. Ohashi’s lab is focused on helping the immune system make this distinction. She explains, “It is important that our
bodies respond to viruses which are foreign invaders, and not respond to our own tissues. When this process breaks
down, people can develop diseases such as diabetes. Our goal is to understand what prevents our immune system
from attacking our own tissues, and use this knowledge to direct the immune system to destroy any tumours that may
arise in our body.”
The Campbell Family is Focused on the Benefits of Long-Term Investing
Financial planners typically recommend that their clients adopt a strategy of ‘long-term investing’—
focusing not on the daily ups and downs of global stock markets, but on a long-term positive outcome.
The Campbell family has adopted this strategy in its relationship with The Princess Margaret.
Their support over the course of their association with this cancer centre now totals $67.5 million, representing the largest cumulative private gift to cancer research in Canada. Audrey Campbell began this legacy
of support to basic science research back in 2004, with the creation of The Campbell Family Institute for Breast
Cancer Research, supporting the work of the esteemed Dr. Tak Mak who is now dedicating his scientific career to
the eradication of breast cancer. Audrey’s daughters, Linda, Gaye and Susan, are continuing their mother’s dedication to cancer research, and their generosity is now supporting research into a broader range of cancers.
The Campbell family’s long-term commitment to basic science research is benefiting cancer patients and their
families today and will be paying dividends well into the future.
4
Enabling Better Outcomes in Cancer Surgery
The Princess Margaret has very successfully pioneered the use of image-guided technology both in radiation therapy
and, more recently, in surgical oncology. Because tumours shift and change in size over time, real-time CT (computed
tomography) images allow radiation therapists to apply radiation much more precisely, sparing more healthy tissue.
All of the hospital’s 17 radiation treatment rooms are now equipped with CT imaging technology.
Similarly, surgeons tasked with the responsibility of removing tumours have a tremendous advantage when they can
see a tumour in relation to surrounding organs, critical nerves, and blood vessels.
While previous technology pictured a 2-dimensional cross-section of an affected area, the new technology generates
1,024 images at once and provides a real-time 3-dimensional picture of the patient’s interior. These images are used
to plan and prepare for surgery, and they can also be updated throughout the surgery, confirming whether the entire
tumour has been removed or whether more malignant tissue remains.
Dr. Jonathan Irish, Head of Surgical Oncology for The Princess Margaret, works closely with Dr. David Jaffray, Head
of Radiation Physics, to determine how best to integrate the new technology in the surgical operating rooms of the
cancer centre.
He points out that, while the new technology is beneficial for all surgeons, it is particularly advantageous for new
surgeons who haven’t had 20 years to develop their ‘sixth sense’ about the positioning of each artery and nerve. This
kind of technology will reduce surgical complications and give young surgeons more confidence.
Visit www.pmhf.ca/onlinereport for videos and more information
5
Generous Gift from the Gattuso-Slaight Family is Paradigm Shifting
Emmanuelle Gattuso is a tenacious and visionary woman who makes things happen. Her
prolific career in media production and public relations includes a long list of positions
and accomplishments including Press Attaché for the Commissioner of Official Languages,
Senior Vice-President of Public Affairs for The Canadian Association of Broadcasters and
producer for Sleepless Nights and The Vancouver Show.
After being treated herself for breast cancer in 2003, she became a strong advocate for
breast cancer patients and has worked with Dr. David McCready, Head of The Princess
Margaret’s Breast Cancer Program, to support research into new screening, diagnostic and treatment programs.
In 2009, she and her husband, media entrepreneur Allan Slaight, made a generous and trailblazing gift of $12.5
million to create The Gattuso Rapid Diagnostic Centre. They have also committed to lead a fundraising campaign
to secure the remaining $12.5 million to complete the Centre which will be a model for other cancer centres in
Canada and beyond.
A Confirmed Diagnosis and Treatment Plan in a Single Day
Thanks to ‘seed money’ from The Weekend to End Breast Cancer, The Princess Margaret was able to purchase a
piece of equipment and test a new approach to the care of patients coming to the hospital with symptoms of breast
cancer. Dr. David McCready, Head of the Breast Cancer
Program, was concerned that patients were waiting an average of 37 days for a confirmed diagnosis and treatment plan.
The equipment, called an XPress Rapid Tissue Processor,
enables pathologists to analyze breast tissue specimens
acquired through a core biopsy within several hours. This
means that a patient arriving at the hospital between 8 and
10 in the morning can have a physical examination, mammogram, ultrasound and biopsy completed, and then meet with
a member of the surgical oncology team in the afternoon for
a report on the findings. If indeed the tumour is malignant,
the treatment plan can be provided on the same day.
Since inception, over 550 patients have experienced this
new approach.
The experimental phase of the program has completed, and
thanks to a generous donation, it is being expanded and
double the number of patients (750 per year) will now benefit
from this rapid diagnostic procedure. By 2013, additional
funding will allow the program to diagnose 3,000 patients
per year.
The Princess Margaret is hoping to partner with nearby hospitals as well as other regional cancer centres to ensure sufficient capacity for follow-up surgical and radiation treatment
and to enable a broad base of patients to take advantage of
this rapid diagnostic service.
6
Understanding What Fuels a Tumour
The past ten years
have been a fertile
period for scientists
in terms of understanding differences between
how normal and
tumour cells grow
and proliferate.
Tumour cells are
very often growing
in a hypoxic or low
oxygen environment. This is partly
due to the fact that
the blood vessels
established to
supply blood to the
tumour are leaky
and not as efficient
as the system of
vessels and capillaries established in
healthy tissue.
Like all cells,
tumour cells need
fuel and, in fact, they are mega consumers of glucose. This large consumption of glucose is one of the ways tumours
adapt to the low oxygen environment.
Dr. Brad Wouters recently returned to Canada after establishing a thriving radiation biology research program in
the Netherlands. He is leading the Hypoxia and Microenvironment Program at The Princess Margaret and his lab is
focused on understanding and then exploiting the vulnerabilities of tumour microenvironments (like the low oxygen
environment) for improved cancer detection and treatment.
Dr. Michael Milosevic is a radiation oncologist and one of the three directors of the STTARR Innovation Centre which
is focused on radiation therapy research. He specializes in the treatment of gynecological and prostate cancers, and is
currently leading several patient studies focused on understanding how abnormal tumour blood flow and metabolism
influence the response to treatments like radiation therapy. One study, for example, is combining the use of a drug
that blocks the formation of new blood vessels with radiation treatment.
In his patient studies, Dr. Milosevic is using special MRI and CT scans to measure and map out blood flow to tumours
and to observe how leaky the blood flow is. PET scans and a new approach called bioluminescence imaging, which
can provide valuable information about tumour metabolism, are also promising tools his team is looking to employ.
Drs. Wouters and Milosevic are sharing their knowledge of tumour metabolism and collaborating to identify
better ways to treat patients. They represent the synergy that exists between laboratory and clinical teams at
7
Kensington Health
Centre and The
Princess Margaret
Partner to Establish a
World-Class Hospice
In the heart of Toronto, Kensington
Health Centre is converting its
historic chapel to a state-of-the-art
hospice home to provide end-of-life
care for central Toronto residents.
Fortunately, just around the corner,
The Princess Margaret has established an outstanding reputation in
this area of care, and an affiliation
between the two organizations will
allow Kensington to benefit from
the latest knowledge, research and
expertise assembled at the worldleading cancer centre. The Princess
Margaret palliative team will:
• W
ork with the Kensington
healthcare team in applying the
palliative care model developed
at the hospital to the resident
hospice setting
• Share information regarding
comfort measures (pain management and bereavement
counseling)
• Implement multidisciplinary
education and establish a collaborative clinical research program
• Establish e-health processes
for sharing treatment plans and
patient-related information
Brian McFarlane, President and
CEO of the Kensington Health
Centre, is delighted that his team
will be working side by side with
“internationally-renowned experts in
the field of palliative care, education
and research.”
8
Ensuring Quality of Life Throughout
the Cancer Journey
For so many
of our patients
and donors,
palliative care is
a high priority
and an area
they want to
see expanded.
Palliative care
refers not only
to end of life
care, but to all
the services
involving pain
Visit www.pmhf.ca/onlinereport for video
and symptom
control,
psychological
well-being and social support of cancer patients and their families.
The psychological impact of a life-threatening cancer diagnosis can be
devastating, and the hospital has responded by developing a wide range
of services for palliative and supportive care. We have a large multidisciplinary palliative care team, daily out-patient palliative care clinics, a
palliative care consultation service, and a 10-bed in-patient palliative care
unit. Psychosocial services include individual, family and group counseling, chaplaincy services, and a Web site called Caringtotheend.ca, where
information and experience are shared with other cancer centres and
their patients.
Dr. Gary Rodin, Head of Psychosocial Oncology and Palliative Care, is
proud that this hospital, thanks in large part to Foundation donors, is
able to “influence cancer care in the world”.
Research is vital to this area of care, as it is to all areas of the hospital,
and clinical trials are being performed to study the impact of early
palliative care and psychosocial interventions and to understand how
best to help cancer patients suffering from depression, memory loss
(‘chemobrain’), fatigue and chronic pain.
The Al Hertz Centre for Supportive and Palliative Care, which will be
established in the fall of 2009, illustrates the importance that The Princess
Margaret places on providing patients and their families with a supportive environment that helps preserve their emotional well being, as they
live with cancer. The staff involved in setting up the Centre understand
that palliative care is as much about supporting the family and caregivers
as it is about supporting patients, and the programs and resources being
developed in the Centre reflect this.
Crunching the Numbers
Cancer research involves intensive study of human genomics, and the
volume of data associated with just one person’s genome is huge,
creating a significant need for specialists who can figure out the most
efficient way to integrate, analyze, visualize and interpret the data. In
addition to developing new algorithms and programs for cancer informatics, there is a major challenge to harness enough computing power
to perform the data analyses in a timely manner.
In the past year, the computational biology team, headed by Dr. Igor
Jurisica, has been working closely with the lung cancer site group trying
to answer the question of why some patients with early-stage non-small
cell lung cancer responded well to chemotherapy in combination with
surgery, while others did not.
Genomic analysis of lung tumour samples from these patients led
senior researchers Dr. Ming Tsao and Dr. Frances Shepherd to isolate
a particular gene ‘signature’ or biomarker that differentiated these two
patient groups.
The team took this discovery to the next stage and confirmed the
predictive power of this genetic signature against publicly available
genetic data from other lung cancer patients. “One of the great advantages for researchers today is the requirement by the major scientific
journals to make the data associated with major papers available publicly,” explains Dr. Jurisica. “This ensures that biological data is collected
and published in a standardized way. It can then serve many studies and
accelerate research.”
An industry partnership with IBM that has been in place for about ten
years has been highly beneficial for both partners. IBM provides needed
computing power and software infrastructure for the hospital’s computational gurus, typically on their newly-developed platforms, and our
data experts test out their
new hardware and software
and provide feedback to the
developers.
The computational biology
team gets some of their computing horsepower from the
World Community Grid—a
network of over 1.2 million
connected computers worldwide. Dr. Jurisica and his team
are also figuring out how
to leverage the computing
power available on graphics
cards (called GPU) for certain
computational tasks.
Invest in Research
Investment
clubs have
been popular
for some time.
The idea of
pooling funds
and sharing
information
on the best
opportunities
for a good
ROI is appealing on many fronts.
This idea is now being applied to
philanthropy an investment club
where the ROE is the opportunity to
actively participate in the vision to
Conquer Cancer In Our Lifetime..
Tom Ehrlich was treated for cancer
at PMH, and when he asked his
doctor how he could help the
hospital that had just helped him,
Dr. Mary Gospodarowicz told him
about the important research ‘in the
funnel’ that urgently needed funding. That conversation, together
with Tom’s great network of friends
and work colleagues, spawned the
Invest in Research Program.
Tom put together a ‘club’ of 25
people, and set a goal for the
program to raise a pool of $1 million
over the course of five years. Each
year they would pay out $200,000 in
support of research projects.
For the inaugural year, a short list
of six proposals vetted by hospital
research leaders was reviewed by
Invest in Research club members.
They chose to award two grants
of $100,000 each—one is supporting research into a promising new
drug for leukemia patients, and the
other funds a study of lung tumour
formation.
Visit www.pmhf.ca/onlinereport for video
9
de Souza Institute Surpasses Five-Year Goals in its First Year
Anna Maria de Souza, who passed away in September of 2007,
was a legend of Canadian philanthropy, and even as she herself
was being treated for cancer at The Princess Margaret, she was
planning her annual Brazilian Ball to raise funds for the hospital.
She wanted the 2008 Ball to pay tribute to the extraordinary oncology nurses who support patients and their families as they deal
with the diagnosis and treatment of cancer, and to also raise funds
for cancer research at The Campbell Family Institute.
Together with her beloved husband, Ivan, she also planted a seed
that has already germinated and borne fruit for oncology nurses
in Ontario. The funds raised by the Brazilian Ball for oncology nursing laid the groundwork for the de Souza Institute, an organization
dedicated to helping meet the increasing demand for more nurses
trained in oncology.
The mandate of the de Souza Institute is to work in concert with
academic and accreditation bodies to develop and deliver a broad
range of oncology-related training as well as mentorship programs
for nurses across the province.
The inaugural director for the institute is Dr. Mary Jane Esplen,
a clinician, professor, author and scientist, well-regarded for her work in psychosocial oncology, women’s health and
palliative care. Dr. Esplen has put in place an ambitious plan for the de Souza Institute and has already over-achieved
in many areas. Just some of the accomplishments of the first six months include:
w14
Ontario regional cancer centres received a total of $1.4 million from the de Souza Institute for information
technology and physical space for nurses to study
w31
oncology nurses in Ontario who are enrolled in graduate-level programs received de Souza fellowship awards to
advance their career development in clinical practice, research and nursing leadership
wOver 150 oncology nurses either enrolled in de Souza study groups or received funding to prepare for the 2009
Canadian Nurses Association national certification exam in oncology or hospice palliative care.
Ontario Government Provides $15 Million for Oncology Nursing Centre
Anna Maria de Souza’s wish to recognize and support oncology nurses led to a meeting of her husband, Ivan de
Souza, Foundation CEO Paul Alofs and representatives from the Ministry of Health and Long-Term Care.
The idea of a centre of excellence to develop and provide education and mentorship programs for oncology
nurses across the province resonated so well with the goals of Cancer Care Ontario and the Ministry of Health
that the Ontario Government announced in May 2008 that it would provide $15 million over five years to support
this centre of nursing excellence, which is headquartered at The Princess Margaret.
While the survival rate for most types of cancers has been increasing steadily, the incidence of the disease also
continues to grow, and the oncology nursing force has not kept pace.
“Oncology nurses play a vital role for cancer patients and their families throughout the cancer care continuum,”
said Terrence Sullivan, President and CEO, Cancer Care Ontario. “Initiatives like the de Souza Institute are important to help make sure that Ontario nurses have access to ongoing educational support and professional development to play an expanding role in meeting the needs of the growing cancer patient population.”
10
“The Biobank Was a Project That Really Resonated With Us”
With his wife, Candace, on the Board of Directors for The Princess Margaret Hospital
Foundation, Eric Innes knew about the work going on at this world-leading cancer centre. When
he and Candace decided that they wanted to do something significant for the hospital, they
chose to support the purchase of needed equipment for the centre’s BioBank as it was central
to the hospital’s strategic plan and relevant to their own goals.
The hospital identified three pieces of equipment needed for the BioBank to store and manage
patient bio-specimens and corresponding patient data.
The goal was $750,000. The Innes family made the leadership donation, and invited a group of friends to join
them by pledging additional financial support. Reaching this goal and making this major gift to The Princess
Margaret gave Eric great pride as he fought his own tough battle with pancreatic cancer. Eric’s passion for life,
commitment to his family, unwavering optimism and strength of character will be cherished with his memory.
Going Digital (and High Definition!)
‘Going digital’ has been a trend with just about everything for the past two decades, and the use of digital imaging by
the BioBank team is helping to extend the many assets of our bank to the larger scientific community.
As the BioBank staff process donated tissues from our patients either for immediate use by our researchers or for
storage, they are now able to use high-throughput digital imaging (HTDI) equipment to take one or more ‘snapshots’
of the tissue as it would appear under a powerful microscope. Together with other cataloguing information stored
along with the snapshot, the team has created a searchable Web site that is being used to train pathologists and to
show scientists (wherever they may be located in the world) the various samples of tissue stored in our BioBank.
Along with the informatics platform that is being enhanced for the BioBank, digital imaging is facilitating important
collaboration with other academic centres. This kind of resource and knowledge sharing is greatly accelerating
cancer research.
The funds required to purchase the
digital imaging equipment were
donated by Foundation supporters,
and put to use almost immediately!
Use of digital imaging in the BioBank
has many other benefits. “Once we
have tissue images digitized and stored
in a database, we can perform different
kinds of analysis that help us identify
common patterns among groups of
specimens,” explains Dr. Patricia Shaw,
Medical Director of the BioBank.
Digital imaging also helps with quality
control in the BioBank. Once a pathologist has reviewed an image, they are
able to document the usability and
annotate the image for future research.
11
Helping Scientists Pinpoint Culprit Genes
Cancer is a disease of the human genome. It starts with a mutation that you might inherit, or it could develop as a
result of exposure to a carcinogenic compound such as tobacco.
Not all mutations lead to cancer in all people, which is a large part of the mystery of the disease. But scientists have
isolated certain gene mutations that are shared by many cancer patients. Identifying these gene mutations, sometimes referred to as gene ‘signatures’ or ‘biomarkers’, is already leading to better screening, diagnosis and treatment
of the disease.
The Human Genome Project has resulted in an explosion in the amount of information available about our genes.
With a few exceptions, every cell in the body contains a full set of identical genes. But only a small percentage of
these genes are turned on or ‘expressed’, and it is this subset of ‘expressed’ genes that gives each cell unique properties. Further, genes are not like simple on/off lights. They are more like lights controlled by a dimmer switch where the
light can be high or low intensity.
To identify, classify, and visually represent such a vast amount of genetic information is a considerable challenge, and
this is where microarrays and microarray technology come in to play. A microarray is a tool for analyzing how genes
are expressed.
The Microarray Centre, co-directed by senior scientists Drs. Linda Penn and Jim Woodgett, has been in operation for
almost ten years analyzing tissue samples collected in our clinics and being studied by our scientists. “The progress
in those ten years has been phenomenal,” explains Dr. Penn. “When the centre opened, scientists would have to
provide at least 10 million cells in order to do the microarray analysis. Today, the instruments are much more sensitive,
and the same analysis can be done with just a single cell.”
The Microarray Centre now has an international reputation and has served over 700 laboratories in 27 different countries.
Last year alone, over 250 different research projects were supported by the Centre from researchers around the world.
12
“
Our Stories Unite Us
Maggie Bain—just turned 16!
Chris Taylor
I was 15 when I
was diagnosed
with cancer in my
eye. My world
ended! I was
fortunate to have
Princess Margaret
two hours down
the road. Dr. Simpson said he’d perform “plaquing” so
my eye could be saved. He’s the only man in Canada
that “plaques”. I had hope! Because everyone took
care of me at Princess Margaret, I have a life ahead
and, as the commercial says, “I can watch my brother
grow up!”.
I am an optimistic
person by nature, but
a diagnosis of nonHodgkin’s lymphoma
made me feel like I was
‘running out of time’.
I’ve been through
several rounds of chemotherapy and a bone
marrow / stem cell transplant. They have been tough
procedures, but the outstanding care and genuine
interest in my well-being from Dr. Hans Messner and
all of the medical staff at Princess Margaret gave me
the hope and confidence I needed to face each day.
Bonita Havelock
Susan McLean Woodburn
Dr. Bezjak and
her colleague
Janet have been
wonderful. Not
only have they
been supportive
and pro-active
thru-out all of my
cancer ‘adventures’, but they’ve been honest with me,
which I appreciate so much. No matter how my story
ends, I know that they have helped stretch that ending
out an extra 4 years, and for that, myself and my family
will forever be grateful. PMH has helped prolong my
life, so thank you!
I’m so grateful. My
incredibly gifted
surgeons, Dr. Peter
Neligan and
Dr. Stefan Hofer, and
the PMH staff were
filled with care, compassion and even a sense of humour. After 16 surgeries in 6 years, my features were restored in an amazing
way - a miracle from my perspective.
Rita Lomagno
I was so afraid when
I was first diagnosed.
Now, one year later
under the care of my
wonderful physicians
at PMH, knowing
that I’m at one of the
best facilities for medical treatment is reassuring. I am
fighting the greatest fight of all – cancer. The Princess
Margaret staff are looking after me, and for that I am
truly grateful!
Mari-Jayne Woodyatt
Over the years,
The Princess
Margaret has
been able to
transform itself
from a hospital,
to a place that
offers hope for
our future. Through the researchers, doctors and
nurses, charities and donors there is an army of silent
hero’s all working together to show the power of ordinary people making a difference in our lifetime.
”
Visit www.pmhf.ca to view these patients and others in the In Our Lifetime video.
13
Special Events
1st Annual Golf For A Cure
5 Steps to Achieving Your Dream
Concert
5K Your Way
A & P Canada Produce Division –
2008 Golf Tournament
A Christmas Wonderland
A Night in the Past for a Cure in the
Future
Al Humphrey Memorial Ride
Angela’s Cause
Annual Mike Dickinson Grey Cup
Event
aWEARness - Giving Voice to the
Whispers
Beth David B’nai Israel Beth Am
Fashion Show
BLJC Charity Golf Charity
Brave Heart Life Party
Brazilian Carnival Ball
Breast Friends Ball
B-Strong Event
C. Darryl Mackenzie Event
Cabin Fever
Canadian Computer Charity Golf
Classic
Charles Krowitz Woodchuck Golf
Classic
Chocolate Ball
14
CMK Golf Tournament
CMRRA Golf Tournament
Color me Pink
ConKer Ride
Crop for the Cure
Cruisin’ for a Cure
Cutting It Close for Cancer
Daniela’s Baseball Charity Potluck
Party
Dave Fleet - Boston Marathon
Dick Aldridge Charity Golf Classic
Divine Mercy 10th Anniversary
Ernie Tourney
Euchre Evening
Extrudex Aluminium Golf
Tournament
Firefighters Against Cancer’s
Existence
Fish TV – Celebrity Fish Tournament
Freed Family Gatherings
Friends For Life Gala
Friends Forever
Friends of Firestone
Gail Phillips Memorial Golf
Tournament
Get Rec’d
Hair Today Gone Tomorrow
Harry’s Spring Run Off
HeArt of Yorkville
Heidi’s Golf Classic
Hi Ho Silver and Chai Cha Na 2nd
Annual Golf Tournament
Holly Bear Tournament
Hunt for the Cure
In Memory of Les Bartley (Toronto
Rock)
Issie’s Quest
Jane Martin’s Art Exhibit
Jimmy’s Food Sales
Jo-Ann Cooke Family Foundation
Gala
Joe Pace & Sons Contracting Inc.
Joe’s Team Triathlon
John Fortney Cocktail Party
Judy Langstaff
Judy Taylor Golf Tournament
Kelly Silverstein Memorial Golf
Tournament
Lakehead University Head Shaving
Laugh Lines
LBMAO Golf Tournament in
memory of Joe Monteiro
Lifford Boys’ Night Out
Lindsay Herzog Necklace Sale
Little Wonders Bring Smiles
LIVE FREE Walk for Cancer
Research
Live Life Large
Locks of Love
Looped for Life Golf Tournament
Lucky Power Memorial Golf
Tournament
Machado Event - Circle Of Friends
Mad Hatter’s Walk
Maple Downs Ladies Annual
Pro-AM Tournament
Maria Campos Leal Fundraising
Event
Michelangelo Gala
Mindy Kirsh Memorial Bridge to the
Cure
Most Wanted Fashion Show
motoamoré
Nana’s Tea Party
Noble Trade Guarantee
Opera for Oprea
Panda Bears Walk
Paolo Ardizzi Fund Reunion
Passion 4 Fashion Cancer
Pedal Against Cancer
Lynne Terry Pencer Centre
Fundraiser
Pink Positive
Power to Cure
Project Cure Paola’s Fund Golf
Tournament
Project Give Back
Purple Vogue: Couture for a Cure
RACH 3-Pitch Tournament
Rapini’s Ristorante Fashion Show
Ratech Golf Tournament
Rebecca’s Hope Charity Cruise
Ride for Heart/Ride for Ed
Rosethorn Tennis Weekend to
Conquer Cancer
Ross Forfar Memorial Golf
Tournament
Sarah Tasswill’s Class Bake Sale and
Barbecue
Shades of White Silent Auction
Shoppers Drug Mart Tree of Life
Campaign
Skate 4 Cancer
Skate with Daniel
Spin 180 Spinning for a Cure!
Stayin’ Alive Disco Party
Strike Out Cancer
Taylor Cup Pond Hockey
Championship
Testicle Festival
The Bud & Doug 1st Annual
Memorial Golf Tournament
The Gary Warner Memorial Golf
Tournament
The Gerry Pencer Golf Tournament
The Gerry & Nancy Pencer Brain
Trust Noir Gala
The Jack B Elie Memorial Golf
Tournament
The Master Insulators’ Association
Charity Golf Classic
The Purple Purl Calendar
The Robert & Maggie Bras and
Family New Drug Development
Program Spotlight Tribute
Todd Wonacott Memorial Curling
Tournament
Toronto Fire Fighter Calendar
Toronto Fire Fighter Magic Show
Toronto Marathon
Toronto to Washington DC Cancer
Ride
UHN Pharmacy Calendar
United Synagogue Day School
Sports Day
Vaffi Salon Fundraiser
Valle Peligna Socio-Cultural
Association
Vanstone Christmas Party
Voice of Reason CD Sales
Waves of Hope
Wings of Life
Wooden Sticks Invitational
Wyatt Pellew Tennis Tournament
Yard Sale for the Cure
15
Special Events
Sexy … Sleek … Sumptuous
The fundraisers behind The Gerry and Nancy Pencer Brain Trust deserve top
marks for creativity and knowing how to execute on a theme. There’s been
Viva Las Vegas, Wild Wild West, Circus Circus, Bell Bottom Bash and many
others, and this year they wanted their guests to get in touch with the sultry
and mysterious side of themselves with Noir.
Patrons were encouraged to indulge themselves at the seductive silent auction, unleash their inner rock star on the dance floor, and seduce their taste
buds with the sumptuous food provided. On the live auction block was a
luxury vacation in India, a Los Angeles Escape, and a Spyder 300 Motorcycle!
An energetic crowd of over 800 people partied the night away at The Liberty
Grand, raising critical funding for research and patient care at The Gerry &
Nancy Pencer Brain Tumor Centre at Princess Margaret Hospital.
It’s Amazing What You Can Do When You Have Friends For Life!
Carol Olsen, like all cancer survivors, knows that each day of life is precious, and she has made it a priority each year
to thank the hospital that gave her another chance at life. She and her husband, Jeff, and 12 of her friends organize
an annual gala that has now raised close to $700,000 in support of bone marrow transplant programs at The Princess
Margaret.
“A bone marrow transplant saved my life—twice,” says Carol, “and that has allowed Jeff
and I to spend more time together and with our many friends. Our event each year is an
important way of recognizing how blessed we are and how grateful to the doctors and
staff at The Princess Margaret.”
For 10 years now, the Friends for Life Gala has been bringing together over 500 people
aged 30 to 60 to enjoy music, have fun and celebrate life.
aWEARness…Shopping for a Great Cause
In May of 2008, a new event was launched in support of The Princess Margaret. Elana
Waldman, a cancer survivor herself, teamed up with fundraising specialist Michelle Levy,
and they put to work their fashion sense, their contact lists, their keen instinct on how
women like to spend their time, and their passion for conquering cancer. The event
provided over 200 guests with a unique shopping experience where they could purchase
designer fashions at greatly discounted prices.
Ladies, men’s and children’s clothing, accessories, sportswear and bridal wear were all
generously donated by designers, manufacturers, and retailers. The labels included Ralph
Lauren, Vera Wang, Michael Kors, Strellson, Zegna, Nicole Miller, Pink Tartan, Theory and
Badgley Mishka. Clothing that wasn’t sold was auctioned on eBay Canada’s charity site.
The event raised over $200,000 for ovarian cancer research… proof that these two ladies
know that an afternoon of food and shopping at a venue like The Liberty Grand is a great
way to bring a group of women together!
16
Strategic Initiatives
The Ride to Conquer Cancer—All the Ingredients for Success!
Bringing together 2,850 bike riders from 8 provinces, 16 states,
and 4 countries for a first-time event is not an easy feat. Helping
them reach out to over 100,000 donors and raise $14.8 million is
even more impressive. But the Foundation’s experience running
large events in combination with our important cause, which is
close to the hearts of so many, made it happen. That is why The
Ride to Conquer Cancer, in its inaugural year, surpassed all other
cycling events held in Canada to become the most successful bike
ride fundraiser.
The riders appreciated the exceptional planning that resulted in
plenty of good food and drinks, hot showers to wash away the toil
and sweat, liquid ‘spirits’ to celebrate the physical accomplishment, accommodation for everyone at the end of the first day, and a festive return train ride from Niagara Falls.
The volunteer support and participation of so many hospital staff made the event very special. So special in fact that
857 people who participated in 2008 signed up on the spot for the 2009 Ride!
The Princess Margaret Creed Showcased in New Television Commercials
In 2008, Y&R, a leading advertising agency providing pro bono services to the Foundation, created a creed (see
page 1 of this report) that captured in words both the vision that drives the people who work at The Princess Margaret
and the innovative spirit that has permeated this world-leading cancer research centre for over 50 years.
This past year, the agency was busy imagining how those words could
be captured visually, and the result is a powerful series of 30- 60- and
90-second videos that do great justice to the words of the creed.
Doctors, nurses, researchers and other staff, volunteers, plus patients and
their caregivers contributed their time, their stories, and their deep feelings
of appreciation.
To see the 90-second advertisement, visit www.pmhf.ca. We invite you to
share this inspiring message by sending the link to your friends and family.
The Weekend to End Breast Cancer Raises $13.5 Million
The fundraising success of The Weekend to End Breast Cancer is 100 percent due to
the passion and commitment of the walkers. For six years now, they have asked their
family and friends for support; organized bake sales, pub nights, pancake breakfasts,
garage sales, raffles and auctions; as well as campaigned outside stores and malls
asking for donations. Walkers have also grown and shaped the event in so many
positive ways by creating great costumes and team names, sharing their personal
stories, and providing suggestions for how the event can be bolder and better.
Those suggestions included the idea of a one-day walk in addition to the two-day
event, and the request that walkers have the option to fundraise for gynecological
cancers, in addition to breast cancer. The Foundation listened and is implementing
these suggestions in the 2009 Weekend to End Breast Cancer.
17
Donor List
The following donor lists show actual gifts received and pledge payments made during the fiscal year April 1, 2008
to March 31, 2009. Donations made in support of participants in The Weekend to End Breast Cancer and The Ride to
Conquer Cancer are listed in our online Donor List which you can find at www.pmhf.ca/donorlist.
w denotes donors whose giving includes an estate gift
$5,000,000+
The Campbell Family
$1,000,000 - $4,999,999
Dr. Geoffrey R. Conway
Memorial Foundation
Susan E. Grange
Allan Slaight and Emmanuelle
Gattuso
$500,000 - $999,999
AstraZeneca Canada Inc.
In Honour of Al Hertz
The Muzzo Family
OSI Pharmaceuticals
Foundation, Inc.
Maneck Sanjanaw
Gordon Tozer
$250,000 - $499,999
Anonymous (1)
Anne Barootesw
David and Molly Bloom
Eric and Heather Donnellyw
In Honour of Al Hertz
Eric and Candace Innes
International Union of
Operating Engineers
Local 793
In Honour of Melissa Ann
Katzman
James S. Kinnear and Bridgette
Eansor
Jon and Nancy Love
Florence Isabel Montgomeryw
The Gerry and Nancy Pencer
Brain Trust
Toshiba of Canada Ltd.
Family and Friends of Lusi Wong
$100,000 - $249,999
Anonymous (2)
Abraxis BioScience, Inc.
David and Sharon Aello
Keith Ambachtsheer and
Virginia Atkin
Bram and Bluma Appelw
Ben and Hilda Katz Charitable
Foundation
Ian and Anne Devine
Anna-Liisa and Graham
Farquharson
Irene Helen Feuerw
Fraser Mackenzie Ltd.
Bruce Galloway
Michael and Libby Goldgrub
Greenpark Homes
The Gucciardi Family
Margaret Joan Howlettw
18
Imperial Oil Foundation
Allan Kerbel and Family
Stephan and Sophie Lewar
Michael Albert Garron
Foundation
John Edward Montgomeryw
Karen and Paul Morton
Gordon and Janet Nixon
Mary Pawlyk and George
Onyschuk
Donald William John Piercew
Play in Support of Cancer
Research
Anna Rollingw
Scotiabank
SOBEK Investments Ltd.
Sherry Taylor Drew
Marie Ella and Edward G.
Thompson
Lucie Tuch Homburgerw
The Westaway Charitable
Foundation
Jack and Anne Weinbaum and
Family
$50,000 - $99,999
Anonymous (1)
Hazel May Arnoldw
Arnott Family Trust
The Asaro Family
Bayer HealthCare
BLJC
Anne Marie Brownleew
David and Paula Butterfield
Camrost-Felcorp Inc.
Canadian Brain Tumour
Consortium
Canadian Cancer Society
Valerie Sharon Dawsonw
Domenic and Bernisea Dell’Elce
Anthony and Shari Fell
Financial Services Department
U of T
Harry Rosen Inc.
Hbc - the Bay, Zellers, Home
Outfitters
Janssen-Ortho Inc.
Warren and Debbie Kimel
Lamarche Family Foundation
Joseph Neville McCarthyw
Ronald John Charles McQueenw
Menkes Family
Charles Franklin Miller and
Donna Marie Piper Millerw
Minto St. Inc.
A. R. Deane Nesbitt
Ortho Biotech
Alice Robertsw
Roche
sanofi-aventis
Schering-Plough
SGNC Charitable Trust
Samuel Sivitzw
Kevin M. Sullivan and Family
The Joe Di Palma Brain Tumor
Pediatrics Foundation
The Lillian and Don Wright
Foundation
The Posluns Family Foundation
$25,000 - $49,999
Anonymous (1)
Abbott Laboratories Ltd.
Amgen Canada
Asbestos Workers Local 95
Bailey Metal Products Ltd.
Howard L. Banting
BML Group of Companies
Robert Breadner
B-Strong Fund
The Family of Sandra Lillian
Campbell
Cancer Care Ontario
Cara Operations Ltd.
Carpenters Union
CGC Inc.
Core Oncology
Norman C. Crook
Davies Ward Phillips & Vineberg
LLP
Rosemary Rita Deleow
Deutsche Bank Securities Ltd.
Primo I. Di Luca
John Di Poce
Tom and Karen Ehrlich and
Family
Eli Lilly Canada Inc.
Lisa Elia Walsh
Senator Jerry and Carole
Grafstein
Giovanni and Concetta Guglietti
Family Foundation
Mojgan Hajmoemanian
Kathy Harder
Jilla and Robert Williams
Foundation
Khodkar Investments Inc.
Morris and Sari Krandel
Edward and Frances Lee
Local 67 - United Association of
Journeymen & Apprentices
Esther and John Loewen Family
Marjorie Logan
Bartlett and Sandra MacDougall
Manulife Financial
Peter Marrone
The Matthews Family
Evelyn Henderson McAndreww
James Hubert McLeanw
McMaster University
McMillan Binch
Milli Ltd.
Ontario Sheet Metal Worker’s &
Roofers Conference Inc.
Osler, Hoskin & Harcourt LLP
Eleanor and Laurence Pattillo
Pfizer Canada Inc.
PMH Dental Associates
Katharine Joyce Pomantiw
Prostate Cancer Canada
Peter and Tina Rocca
Rogers Group of Companies
Sage Investments Ltd.
Martha and David Shaw
Stanley and Donna Shenkman
Sherman Foundation
Shorcan Brokers Ltd., TSX
Group
Stayin’ Alive
Steed & Evans Holdings Inc.
Paul M. Stein
The Bank of Montreal
The Mariano Elia Foundation
The Norman and Marian
Robertson Charitable
Foundation
The Tecolote Foundation
Vitas Properties Ltd.
$10,000 - $24,999
Anonymous (2)
2138183 Ontario Ltd.
A & W Pharmacy
A Night In The Past For A Cure
In The Future
Leonard and Marcy Abramsky
Ronald J. Adams
Al and Malka Green
The Alofs Family
Jim Archer-Shee and Mary
Matthews
Arista Homes
Aspen Ridge Holdings Inc.
Stuart Lazier
A. C. Baillie
Marvin and Linda Barnett
Bayshore Capital Inc.
Hilda Beaucagew
Bob and Diann Bell
Michael Benjamin and Family
Berkow, Cohen LLP
Beverley Joan Bernierw
Bliss Photography
Blu Skye Health Inc.
Blue Sky Capital
Bondfield Construction
Company Ltd.
John H. Bowey
Brain Tumour Foundation of
Canada
A Partner in the Healthcare Community
As a company with deep roots in Canada, Imperial Oil is committed to making investments that build strong and
healthy communities. Their gift of $500,000 will support the hospital’s Mesothelioma Research Program. The funds
will be used to support the development of new approaches to mesothelioma treatment and the translation of
basic science discoveries into the clinic.
Mesothelioma is a disease most often caused by exposure to asbestos, and PMH is a world leader in the early
detection and treatment of the disease. The ‘mesothelium’ is a protective lining that covers most of the body’s
internal organs, but the disease is most frequently found in the pleura—the outer lining of the lungs and internal
chest wall.
The expertise PMH has developed in the use of computed tomography (CT) imaging is being used to see and
diagnose mesothelioma at an early stage. A screening program
for workers exposed to asbestos launched in early 2005 and over
900 people have now been screened using CT technology.
A comprehensive biobank of mesothelioma tumours has been
created and is being used to test innovative new treatment
options which include the development of new drugs that target
specific molecules within mesothelioma cells, ‘whole lung
radiation’ prior to surgery to prevent the cancer from spreading,
and therapy that boosts the body’s own immune system to attack
the mesothelioma.
Brampar Building Supplies Ltd.
Paul Braun
Bristol-Myers Squibb Canada
James Foster Byersw
Canadian Council On Learning
Canso Investment Counsel Ltd.
Celgene
Claire Interior Supplies Ltd.
Esther and Jack Cole and Family
Con-Elco Ltd.
Cooltech Air Systems Ltd.
Coppley Apparel Group Ltd.
Cougar Biotechnology
Culinary Destinations Ltd.
Robert Daniels
Deborah D’Arcy
Davis & Henderson Ltd.
Della Shore Investments
Samuel and Claire Duboc
David Dulberg
Dunpar Developments Inc.
Paul Dykeman
Dynamic Fund Foundation
Kaelen Farncombe
Nina and Robert Farquharson
Fenig Management Ltd.
Firefighters Against Cancer’s
Existence Foundation
First Quadrant LP
Vito and Mary Ann Forte
George and Judy Frankfort
Peter L. Fraser
Front Street Capital
Frank Fusillo
G.A Paper International Inc.
Gail Phillips Memorial Golf
Tournament
Yola Gambin
Georgia-Pacific Gypsum
Gerry and Caren Ruby Family
Foundation
Phil Gillin and Ava Sands
Gluskin Sheff + Associates Inc.
Goldman, Sachs & Co.
Griffiths McBurney Canada
Corp.
Niall Hamilton
David and Melanie Harris
Bernie and Sharon Herman
Hugo Boss
John M. H. Huxley
IBM Canada Employees and
Retirees
Imedex Inc.
Interior Systems Contractors
Assoc. of Ontario
JBS Foundation Inc.
Johns Manville Canda Inc.
May and Fred Karp
Martin Kelman
John Krall
Lanno Torelli LLP Chartered
Accountants
Leon’s Insulation Inc.
Lifford Wine Agency
In Honour of Lai Chun Liu
Sheila and Syd Loftus and
Family
Louro Jewellers Inc.
Ian MacKellar
Mackenzie Financial Corp.
Ted Manzaris
Markham Executive Suites Inc.
Masters Insurance Ltd.
Irving and Esther Matlow
Mattamy Homes Ltd.
Eugene C. McBurney
Tom and Lynn McCulloch
Mechanical Contractors
Association of Toronto
Mercedes-Benz Canada Inc.
Merrill Lynch Canada Inc.
Minto Urban Communities Inc.
George Mitchell
Joseph Michael Mudronw
Nathan and Lily Silver Family
Foundation
Robert Nelson
Alfred Isaac Newfeldw
Newport Partners Holdings LP
Novartis Pharma Canada Inc.
Stella Patricia O’Brienw
Ontario Acoustic Supply Inc.
Ontario Council of Painters
Desmond and Pamela O’Rorke
Jean Elizabeth Oswaldw
Marie José Overweel
Owen. Wright LLP
Ozz Electric Inc.
Patene Building Supplies Ltd.
Patrick Hodgson Family
Foundation
Dorothy Pattisonw
George Norman Pearsonw
Pharmaceutical Partners of
Canada Inc.
PMH Radiation Oncologists
Price Waterhouse Coopers
Chris S. Purkis
William and Cynthia Quinn
RBC Foundation
Regal Crest Homes
Reliance Home Comfort
Rexdale Food Specialties Ltd.
Mary Robertson
Helaine and Lionel Robins
Rogers Communications Inc.
Barrie Rose and Family
Mary Anglim Rossw
Family and Friends of Tito
Sansalone
Shepell.FGI
Shoppers Drug Mart
Show One Entertainment Inc.
Jean Simardw
S.O. Asher Consultants Ltd.
Esther Solomonw
St. Lawrence Cement Inc.
Strachans s.a.
Kazimiera Supczak
T.G.H. Otolaryngology Research
Group Inc.
Joey and Toby Tanenbaum
Tauba & Solomon Spiro Family
Foundation
TD Bank Financial Group
TD Commercial Banking-Beaver
Creek Real Estate Group
R. L. Temple
The Buchan Family Foundation
The Griffin Group, Blackmont
Capital Inc.
The Laurier Group
The Norman and Margaret
Jewison Charitable
Foundation
The Roel C. Buck Family
Foundation
The Rudolph P. Bratty Family
Charitable Foundation
Ticketmaster Canada
Trinity Development Foundation
19
Tuchman Family Foundation
Universal Workers Union Local
183
University of Toronto
Vibro-Acoustics
Ronald and Faye Wagner
James A. Waters
Watson Building Supplies Inc.
Western Goldfields
Michael and Shari Wilson
Florence and Mickey Winberg
Wings of Life
Wolters Kluwer Health
Richard Wookey
Yellow Pages
$1,000 - $9,999
Anonymous (57)
116060 Ontario Ltd.
1243690 Ontario Inc.
1353566 Ontario Ltd. O/A
Golden Comb
150 Toro Inc. Himel Group
151797 Canada Inc.
1st Annual Golf For A Cure
2017919 Ontario Ltd.
683731 Ontario Ltd.
771107 Ontario Ltd.
A & M Heat Treating Ltd.
A & P Canada Produce Division
A & W Food Services of Canada
Inc.
A P S Precast
A.W.B. Charitable Foundation
Abacus Architect Inc.
Allen D. Abbott
Abilet Constructions Ltd.
Abitibi-Consolidated Inc.
Ablengineering Steven Little
Tanya Abrams
Acier Wirth Steel
Acker Finley Inc.
Hy and Phillis Ackerman
Actionware
Jason Adams
Mollie Adamson
Renee Addison
Michael Adelson
Advance Tile and Floor
Covering (Toronto) Ltd.
Advantage Crombie Kennedy
Inc.
Aero Plastics Ltd.
Nick Agar
AGF Funds Inc.
Naseer Ahmed
Shahida Ahmed
Aimco Solrec Ltd.
Airboss of America Corp.
Aird & Berlis LLP
Adil Akhtar
Al Humphrey Memorial Ride
Al Palladini’s Pine Tree Ford
Lincoln
Alastair & Diana Gillespie
Foundation
Gino Alberelli
20
Peter W. Alberti
Alcoa Inc. – NAPM
J. A. Alexander
Algonquin Airlink
Mohammad Alkari
All Star Carpentry
Allan and Susan Fenwick
Clive and Barbara Allen
Allied Beauty Association
Allstate Insurance Company of
Canada
Lori Alter
Alto Molise Associazione di
Sant’Antonio
Mark and Frances Altow
Altus Helyar
Isabel Alves-Vettoretto
Alvin and Mona Libin
Foundation
Amca Sales Ltd.
Jeanette Anbinder
Anchor Shoring & Caissons Ltd.
Sherry L. Andreucci
Coralie L. Andrew
Quinto Annibale and Dianne
Tarraran
Anton Manufacturing
Mark Appleby
Trevor and Lynda Appleby
Michael Arbus
Ardis Archer
Carolyn Archibald
Ardizzi Financial Services
Ariston Marble & Granite Ltd.
Donald C. Armour
Charles and E. L. Armstrong
Robert G. Armstrong
Armstrong Hunter
Arrow Hedge Partners Inc.
Arthritis & Autoimmunity
Research Centre Foundation
Asbestors Workers International
Asso Paving
Associated Mechanical Inc.
Aubrey & Marla Dan Charitable
Foundation
Eleanor Augusteijn
Automated Interiors Inc.
Maria Aversa
Nancy Avison
Aviva Insurance
E. Ayranto
James Ayres
Verna Aziz
B & D Insulation Inc.
B.C. Music and Consulting
B.P. Foundation Inc.
Shahbanu Babul
Scott and Jaqueline Bachly
Terry Bacinello
William F. Badke
Baelda Holdings Ltd.
Shane Baghai
Jehan Bagli
James C. Baillie
Wilbur N. Baily
Kelly A. Baird
Philip J. and Seta Baker
Baker Real Estate Corp.
Raff and Frank Baldesarra
Paul Balfour
Faith Banks
Edith and R. Bansen
Lawrence Barakett
Barber Stewart McVittie &
Wallace
Gary and Jo Barnes
Douglas and Kathryn Barrington
Tammy Baruch
Zoltan Barzso
Robert Bastianon
Bathe & McLellan Building
Materials
Patricia Bauer
Robert Bauer
Baycliffe Homes
Baywood Homes
Bay-Yorkville Developments Ltd.
BDO Dunwoody
Edwin L. and Elaine Beallor
Geoffrey Beattie
Sally K. Beattie
Roland Beauregard
Beaver Group Inc.
Beaverhall Homes Ltd.
Beaverkill Foundation Inc.
Kimberly Beckman
Bedells Food Service
Distributors
Bob and Diann Bell
Bell Canada, Employee Giving
Program
Bellio Masonry Inc.
Sara Belmont
Belor Construction Ltd.
Belrock Construction Ltd.
Robert Benedek
Benefit Plan Administrators Ltd.
Benjamin Walker Foundation
Benkar Shoes Inc.
Paul Bennett
Maria F. Bento
Gay Berger
Eric and Sheryl Berke
Vera Berkowitz
M. Barbara Berner
Robert Bertram
Bertucci MedSpa
Beth David B’Nai Israel Beth Am
In Trust
Better Iron Works Ltd.
Bianchi Presta Barristers &
Solicitors
Bigwin Island Golf Club
Herb and Fran Binder and
Family
Lenny and Evie Binder
Allan and Lesley Offman
Dave Black
Heather E. Black
Blackmont Capital Inc.
Blake Cassels & Graydon LLP
Frances Blau
BMK Benchmark Inc.
BMO Capital Markets
BMO Commercial Banking
BMO Nesbitt Burns Inc.
Oliver Bock
Oriente Pol Bodetto
Boiler Inspection & Insurance
Co.
Bolton Railings Inc.
Michael Bondy
Bora Investments Ltd.
Marius Bordan
Borden Ladner Gervais
Patrick Borg and Nancy Olive
Paul and Theo Marie Borg
Eric Bornstein
Robindra N. Bose
Helen G. Balfour
Walter M. and Lisa Balfour
Bowen
Walter Boyd
Peter Braaten
Gordon Brace
Audra Bracken
J. Lorne Braithwaite
Bob Brakel
Brandon Communications
Brant Flour Mills Ltd.
Barbara Bregman
Yetta Bregman
Shlomo Brenner
William and Mari Brereton
Brickworks Communications Inc.
Bridge to the Cure
Bridgewood Carpentry Ltd.
James Brierley
David Brill
Brimstone Holdings Ltd.
David I. Bristow
John Brittain
George C. Britton
David Broadhurst
Timothy and Barbara Bromwich
Terry Brooks
Brovi Investments Ltd.
Philip and Terry Browman
Douglas Brown
Howard Brown and Kimberly
Cohen
Jeanette Brown
Brown Window Corp.
Jim and Anna May Bruce
Daniela Bruns
Bryan Pilutti Chartered
Accountant
Lori Buchholtz
Jack and Roma Buchman
Leanne Buck
George Buckles
George Buckley
Irene Budd
Jason Budovitch
Burgundy Asset Management
Ltd.
Michael F. Burke
Alexander and Gladys Burns
Ronald Peter Butler
Jessica Butt
Marion Buttars
Buttonwood Real Estate
C. Bowen Designs Inc.
C.M.I. Canada Inc.
C.W. Shasky & Associates Ltd.
Cabin Fever (Cancer Fund)
Cachet Estate Homes
Ryan Cairney
Brendan and Mary Calder
Norma J. Callum
Calsper Developments Inc.
Jessie L. Campbell
Canada’s Pizza Delivery Corp.
Canadian Alliance Terminals Inc.
Canadian Conference of
Asbestos Workers
Canadian Hospital Specialities
Ltd.
Canadian Pacific Railway
Canadian Partnership Against
Cancer Corp.
Canadian Press/Broadcast News
Ltd. Emp. Charitable Fund
Canadian Prostate Cancer
Network
Canadian Rental Centres
Canderel Stoneridge Equity
Group Inc.
CanGap Lending Corp.
Can-Rad Beauty Ltd.
Gaston Caperton
Carcones’s Auto Recycling
Robert Carew
Eric Carlsonw
William Carlyle
Carolyne Kerr
Mary Carson
Casco Inc.
Casino Vacations Inc.
John and Mary Cassaday
Castlepoint Investments Inc.
In Honour of W. Manson
Catterson
Pamela Catton
Stephen G. Caudwell
Siobhan Cavanaugh
Cedar Infrastructure Products
Inc.
Center-Line
Central Ont. Regional Council
of Carpenters
Century Grove Homes
Joseph Cerasuolo
Cervini Painting & Decorating
Ltd.
Chad Management Group
John Chamberlain
Diane Champaglia
Nicole Champagne
Simon Chan
Anna Chan
Elizabeth Chang
Murray J. Chant
Larry Chapman
Charities Aid Foundation
America
Chatelaine Lighting Supply Ltd.
Dallas and Linda Cheevers
Gord and Margaret Chellew
Chao-Hui Chen
Peter Cherrie
Cheryl Reicin Flow-Through
Fund
Ellen Cheung
Mari Chevrette
Ralph Chiodo
Elizabeth Chisholm
Sheila W. Chiu
Peter Chiu
Chouinard Bros. Roofing
Rosa Mi Yee Chow
Kan-Yan Chow
David and Valerie Christie
William and Inge Christie
Chubb Insurance Company of
Canada
CIBC
Sam Ciccolini
Frank Ciccolini
Citrolad Canada (Juices) Inc.
City Buick Pontiac Cadillac Ltd.
John and Lynn Clappison
Chris Clark
Cheryl P. Clark
Fran Clark
Robert W. Clark
Edna M. R. Clarkw
Joan D. Clayton
ClearCanvas Inc.
Ronald and Lynnette Clegg
Bruce Cleland
Mark Clemons
Eric Clifton
CNA Foundation
James Coatsworth
Jean and Glenn Cochrane
Coco International Inc.
Sidney L. Cohen
Stephen and Roslyn Cohen
Stephen Cole
Colley, Borland & Vale Insurance
Brokers Ltd.
Luciano Colozza
Columbia University
Combined Insurance Company
of America
Nancy Condo
Condor Properties
Confederation Freezers
Dean Connor
Conros Corporation Tape
Division
Con-Strada Construction Inc.
Gordon Cooke
Jim and Jo-Ann Cooke
Dan Cooper
Gail and Irving Cooper
Joan and Frank Copping
Cesidio Coppola
Coram Constuction Group
Peter Corbo
Corby Distilleries Ltd.
Diane Cordeiro
Core Architects
Coreydale Contracting Co.
Cortex Search Inc.
Sheila and John Courtemanche
Kim Couse
Olga and Warner Cowan
Sharon Craig
Paul and Elvi Craig
Beatrice and Purdy Crawford
Edward H. Crawford
Sheelagh Creaghan
Credit Valley Imaging Associates
William G. Crerar In Honour of
Susan E. Crerar
John and Mary Crocker
Lyla Ada Crossleyw
Kathleen and Philip Cross
Murray Cross
Norman and Grace Cross
Peter A. Crossgrove
Michael Cruickshank
Elaine and Jack Culiner
Jeffrey Cullen
Harry Cummins
Joseph Cundari
Eva and Phil Cunningham
John William Curran
Norma Curran
Joseph and Josephine Currie
Curwood Packaging Canada
Ltd.
Curtis Cusinato
Marty Cutler
Ralph Cutten
Erik Cuzzolino
David and Stacey Cynamon
Ezio Da Dalt
Fern Daiter
Kevin Dalton
Randy Dalton
Penny Damilatis
Daniel and Elizabeth Damov
Kevin Dancey
D’Andrea Contracting Ltd.
Tricia Danner
Archibald R. Dash
Davies Howe Partners
Charles and Cheryl Davis
Arthur C. Dayfoot
Bessie Dayfoot
DC Foods (2110) Inc.
De La Salle College “Oaklands”
Luis E. Fong De los Santos
Elvio and Vicky De Meneghi
Joseph De Tommaso
De Ville Electric Inc.
Peter Deas
Deberadinis Building and
Development Ltd.
David Debora
Decora Window & Door
Systems
Deep Foundations Contractors
Inc.
Jim DeGasperis
Frank and Nella Dell’Elce
Delmeade Constructions Inc.
David Delmedko
Del-Ric Integrated Construction
Graziano Delucchi
Frank Demarinis
George and Katherine
Dembroski
Joanne Dereta
Derek Dermott
Dersean Investments Ltd.
Jean C. Deverill
Peter and Anna Di Giuseppe
Renza De Luca
James Di Luca
Paul Di Luca
G.P. Di Rocco
J. Di Tommaso
Diamondfield Entertainment
Inc.
Paul Dickie
Jim Dickson
R. Dickson
Emanuel DiFalco
Dikla Insurance Co.
Ian Dillon
Dion, Durrel + Associates Inc.
Divine Mercy Catholic School
DLK on Avenue
Lois and Richard Dodds
Colin Doe
Tracy L. Doederlein
Dole Foods of Canada Ltd.
Dolente Concrete & Drain Co.
Dolphin Bingo Sponsors
Association
Erica Domingues
Dominion Caulking Ltd.
Domti Engineering and
Construction Ltd.
Don Valley North Toyota
Donald Construction Ltd.
Michael Dorfman
Dossa Chiropractic Professional
Corp.
Cameron and Lynn Douglas
Kenneth and Sheryl Dowd
Downsview Heating & Air
Conditioning Ltd.
Downsview Kitchens Ltd.
Downsview Plumbing Ltd.
Dr. Jay Charitable Foundation
Drain-Tite Ind.
Lisa and Philip Draper
Rubina Eileen Dreyerw
Drudi
Druxy’s Inc.
Dryco Building Supplies
Owen Duckman
Sandra E. Dudley
Dufferin Peel Association of
Principals and Vice Principals
Dundeewealth Inc.
Gwynneth Margaret Dunhamw
Steve R. Dunk
Donald James Dunlop
Peter Dunlop
Amy Dunn
Laura Dunne
Peter A. Dunne
Michael N. Durisin
Durox Floor Accesosories PS
Inc.
Wayne Dusk
Claude Dussault
Joe Dwek
Gerald and Evelyne Dyck
Philip J. Dykshoorn
E.M.C. Group Ltd.
Mary Eagleson
Keith S. Eaman
Earle M. Jorgensen (Canada)
Inc.
John Eckert
Eckler Ltd.
ECMI Management Inc.
Eco-Container Corp.
Economical Insurance
Estelle Edelsten-Semple
Edenbrook Homes
Edwards Builders Hardware
Edwin and Charlotee Pivnick
Family Foundation
Ehrlich Real Estate Advisors Inc.
Wendy Eisen
Valerie Elia
Elitrex Plumbing Ltd.
Nicole Ellies
Heather Elliott
Elliott & Rina Rosenberg
Elsevier Interactive Solutions
Inc.
ELTE
21
Emblem
John Embry
Empro Ceramic Tile Ltd.
Encore Sales
Luise Enderle
Ensil Canada Ltd.
Epitome Pictures
Susan Erem
Adina Erem-Isenberg
Ericsson Canada Inc.
Peter Erlendson
Philip A. Ernst
Ernst & Young
Escada
Sheila Eshelbyw
Jennifer Everaars
Everest Supply Inc.
F.E.D. Construction
Mark and Anita Fackoury
Mark Faircloth
Falcon Kitchens
Joseph A. Falcone
Agnes Faraci
John Farano
Ross M. Farewell Jr.
Patricia Farquharson
Fast Freight
Basilian Fathers
Peter Favot
FCT Insurance Company Ltd.
FedEx Canada Ltd.
Joseph Fehrenbach
Lawrence Fein
Bernard Feinstein
Angela and David Feldman
Terry Fellner
Allan and Susan Fenwick
Ferrari Maserati of Ontario
Alan L. Ferry
FGF Brands
William Fielding
Kim Fielding
Fiesta Farms
Fifeness Construction Ltd.
Paul Findlay
Isobel M. Findley
David N. Finkelstein
John Finaly
Joe Finley
Renato Fiorito
Sherry Firestone
First Capital Realty Inc.
First Republic Capital
Michael Firth
Christine Fisher
P.L. Fisher
Brendan Flanagan
Violet Flawn
Jack and Toni Fleischmann
Neil Fleshner
Mario Fleury
Flora Di Menna Designs Inc.
Fluxgold Izsak Jaeger LLP
Fogler Rubinoff LLP
Lui Fogolini
Kevin Fong
Paula Fonseca
Forest City Fire Protection Ltd.
Forest Hill North Auto Collision
Nancy Forfar
22
Helen Forrest
Archie Forsyth
Fortis Law Professional
Foster’s Wine Estate Inc.
Four Valleys Excavating
William J. Fox
Douglas C. Fox
Val and Ron Fox
Catherine E. Frame
John Francis
William F. Francis
Lynn Francis
Franco-Nevada Corp.
George Frankfort
David Fraser
Katharine Fraser
Enzo Frati
Gerald and Stella Freedman
Harvey and Miriam Freedman
Sherri J. Freedman
Herbert Frieberg
Joseph and Linda Fried
Harvey Frisch
Sidney Fromer
Harvey and Helen Fruitman
Fruitman Kates LLP
Linda Frum
Colin Fruman
Eileen and Larry Fryer
Robert Fujiki
Ross E. Fullerton
Johnny Fung
Gaetano Gagliano
James A. Gaiger
Paul and Nikki Galbraith
Gale and Jerold Winter
H. B. Gales
Galmar Electrical Contracting
Inc.
Mike and Rocchina Gambardella
Garfinkle, Biderman LLP
Bruno and Renate Gass
Gateway Chevrolet Inc.
Robert Gatis
Pierre Gattuso
GE Canada
David Generali
Generation Carpentry
George and Martha Butterfield
Gerald A. Boyko Dentistry
Professional Corp.
Geranium Corp.
David Gerofsky
M. B. Ghadaki
Ghandour Painting &
Decorating
Gianelli Excavating
Joyce and Harry Gibbard
David Giffin
Giftcraft Ltd.
Ron Gilbart
Bryan Gilbart
Gurjeet S. Gill
Pierre Giroux
Faye Gitter
GK Industries
GlassCell Isofab Inc.
Kurt Gemser
Global Alliance Worldwide
Chauffeured Service Ltd.
Global Management Networks
Inc. (Adeste)
Glober & Cohen, Associates
Lillian and Norman Glowinsky
GM Sansalone Engineering Inc.
Louise Godfrey
Lionel and Mary Goffart
Douglas Gold
Golden Thai Restaurant
Goldfarb, Shulman, Patel & Co.
LLP
Cheryl Goldhart
Goldman, Spring, Kichlard, &
Sanders LLP
Lesli Goldstein
Lorne and Carol Goldstein
David and Bonnie Goldstein
Goldstein Financial Consultant
Goodfunds ( a division of GFI
Investment Counsel Ltd)
Jonathan Goodman
Allan J. Goodman
Susie R. Goodman
Goodmans LLP
Christopher and Jan Goodwin
Donald and Patricia Goodwin
John M. Gordon
Merritt E. Gordon
Howard Gorman
Muriel Gorrie
Mary Gospodarowicz
Richard and Mary Gossage
Gould Leasing Ltd.
Suzanne and Michael Gourley
GPC biotech
Grace and Gilbert Goodman
Allister Graham and Susan
Freeman
Norman Graham
Grace Graham
Karen Graham
Laurie Graham
Robert Graham
William and Gwendolyne
Graham
Mark Grammer
Granny’s Poultry Co-Operative
Ltd.
Stephanie Grant
Rosemary Grant
Trudy Grant
Darcy Gratton
Great Gulf Homes Charitable
Foundation
Great Gulf Homes Ltd.
Karen Green
Robert Green
Jean Green
Lindy Green and Howard
Sinukoff
Green & Spiegel
Green and Ross
Marilyn Green Robson
Francis Greenburger
Wendy Greener
Brian Greenspan and Marla
Berger
Gresta Ltd.
Bruce and Penelope Grierson
Meghan Grifferty
Jeanette and Harvey Grosman
Dafna Grossman
Sylvia Guenther and Richard
Hennessey
Riccardo Guglietti
Silvio Guglietti
Joseph Guillaumew
Stephen Gunn
Domenic Gurreri
Joseph Guss
George and Beverly Guy
H & R Real Estate Investment
Trust
H.W. & Associates
Tracy A. Hackett
Robert Hagerman
Eudice Halberstadtw
Brian Hall
G. Ellen Hall
Hallmark Housekeeping
Services Inc.
Halton Forming (1992) Ltd.
Angie Hamilton
Jane Hanes
Kathleen Hanly
Doris Hansen
Peter Hanson
Hanson Brick
Harbour Sixty Steakhouse
Harbourfront Centre
Harding Display Corp.
Harpell Associates Inc.
Judith Harris
Valerie Harris
Susan and Edward Harsant
Harvest Marketing
Harvey Kalles Real Estate Ltd.
Saul Hauer
Haultec Sales Inc.
Haultec Trailers Ltd.
Laura Hawthorn
Joyce M. Hay
A. Ruby Hayashi
Beatrice Hayman
Arden R. Haynes
HBM Fence & Wire
Heat & Frost Insulators &
Asbestos Workers Local 119
Heathwood Holdings CorpDécor
Heidi Golf Classic
George and Linda Heller
Brian Hellyer
Helm Resources Inc.
Kristi Hendrickson
Hengab Investments Ltd.
Joshua Herden
Peter and Janet Herman
Jeffrey and Elizabeth Herold
Michael Herring
Andrew Herzenberg
Ernie Herzig
Joan R. Hickey
HiHo Silver Resources
Lawrence and Elyse Hildebrand
Hi-Lite Fine Foods Inc.
Hillen Nursery Inc.
Fern Hiltz
Roy and Joan Hintsa
Allen and Celia Hirsh
History Hill Group Inc.
HMG Custom Interiors Inc.
Lok Shan and Lilli Ho
Timen P. Ho and Ling H. Ho-Lai
Tracey Ho Lung
HOK Canada
Lora Holland
Holly Bear Tournment
Marion V. Holmes
R. Brian Holmes
Iain and Mary Ann Hood
Hood Packaging Corp.
Marilyn Hosang
Pamela Mary Hosang
Hung-Chao Hou
John H. Hough
Sylvia Houghton
Wendy Howze
Mike Hramca
Brent Hubbard
Miranda Hubbs
Hude Park Properties
Paul Huebener
William Hughey
Nicolaas J. Hulst
Lois Humphrey
William B. Humphries
John Hunkin
R. Neil and Ann Hunking
C. Lindsay and Susan Hunt
John and Julie Hunt
Hunt for the Cure
Benjamin and May Hutzel
Hybrid Turkeys
I Care Enough Events
I H L Investments Hardware Ltd.
I.A. Michael Investment Counsel
Ltd.
I.E. Weldon Secondary School
Lisa Iantria
Imperial Trim Supply Ltd.
In Memory of Kelly Silverstein
Trust
Independent Plumbing
and Heating Contractors
Association
Industrial Alliance Insurance and
Financial Services Inc.
Industrial Alliance
John and Tracey Ing
Glenna Ingold
International Union of Painters &
Allied Trades-Local1891
Int’l Brotherhood of Electrical
Workers Local 353
Ira Gluskin & Maxine Granovsky
Gluskin Charitable
Foundation
Ironwood Construction
Management
Arnold and Lynn Irwin
Margaret and Kristian Isberg
John and Lucy Italiano
Richard Ivey
J F Brennan Design/Build Inc.
J.B. Aluminum Products Ltd.
J.D.S. Accufinish Ltd.
J.E. Panneton Family
Foundation
J.F. Moore Lithographers Inc.
J.G. Jackson & Associates
J.S. Cheng and Partners Inc.
J.V. Building Supply
J+J Shared Services
Erin Jackson
Umesh Jain
Ken and Mary James
James and Alfreda Parlee Fund
at the Toronto Community
Fdn.
Jan K. Overweel Ltd.
Evelyn M. Janes
Janes Family Foods
Genevieve Jarry
Jasper Construction Corp.
JCO Communications Inc.
Jenry Management Inc.
Jermark Plumbing & Mechanical
Services Ltd.
Edith Jewett
Joe Pace & Sons Contracting
Inc.
John W. S. Preston Foundation
Stanley R. Johnson
Colleen and Brian Johnston
Joint Residential Construction
Association
Pamela Jones
Patrick A. Jordan
Joseph Brant Memorial Hospital
Joss Foundation
Jovan Ducic Canadian Serbian
K.G. G. Contracting Ltd.
K.L.M. Planning Partners Inc.
Kaboose Inc.
Azard Kallan
Elise Kalles
Maria Kalyvas
Robert Kassel
Katherine Newman Design
Chris Kauffman
Nitin and Priti Kawale
Louise S. Kawasaki
Elaine and Jimmy Kay
Barry Kearns
Debra May Kee
C. Patrick Keeley
David Keeley
Patrick and Barbara Keenan
Elaine M. Kehoe
Kenair Apartments Ltd.
Thomas Kennedy
Marion P. Kenney
Peter Kenny
Andrew T. Kerr
Teresa and Norman Kerr
Ian Kidson and Carole McNabb
Bob Kilgour
Mary Kilworth
Andrea, Carolyn and
Christopher Kinch
Gary N. King
Susan and James King
Kingsgate Plumbing & Drain Inc.
Leslie William Kinnellw
Kinross Gold Corp.
Neville Kirchmann and Family
Aletha Kirkwood
Joel Kirsh
Peter Klahsen
Sharon Klinghoffer
John Knebel
Robert Knowlton
Yeong W. Ko
Dana Koeppel
Murray and Marvelle Koffler
Alkis Kontos
Konzco Special Tools Ltd.
Igor Kornyshkov
David Koschitzky
Paul Koster
Marina Kovrig
Bernard Kraft
Kraft Berger LLP
Kraft Canada Inc.
Sarah Krauss
KRG Children’s Charities
Larry Kruitz
Connie Ku
Kal Kuronen and Lois Topham
Kurtz Orchards
Lab Development Ltd.
Labatt Breweries of Canada
Ladies Links Tour Golf
Association
Lafarge Canada Inc.
Michael Laine
Lakeview Homes
Marjorie Lampkinw
Lanciano Social Club
Judith and Bruce Langstaff
Mary Laurence
LawPro
Scott Lawrence
Moira and James Lawrence
Mary Ann Lawrie
Debra Lawson Bridgewater
Theo Lax
Carl Laywine
Leader Plumbing & Heating Inc.
Harley Ulster and Cindy Leder
Esther Lee
Martin J.G. Lee
Andrew and Elaine LeFeuvre
Legendary Motocar Company
Ltd.
David LeGresley
Philip A. Lehn
Ann L. Leibel
Anitra Leksers
Delbert Lemcke
Debbie Lenehan
Kevin Leon
Joseph Patrick Leonardw
Ashley LeRoux
David Leslie
Charles E. Letman
Cowan Leung
Christine Leveque
Weldon Levine
Benjamin Levinter
Steven Levy
Linda Lewis
Jules Lewy
Mike Leyes
Pik W. Li
Jay Liao
Liberty Development Corp.
Marilyn Libin
Sally Libman
Limen Group Ltd.
Perry Lin
Jane L. Lind
Bob Lindsay
Link Charity Canada Inc.
Lauren Linton
Sharon Lipman
Colin Lipson
Jeffrey G. Lipson
Marcia Lipson
Lipton, Wiseman, Altbaum &
Partners
Lisi Mechanical Contractors Ltd.
Live Free Walk for Cancer
Research
Liza Homes
Loblaw Companies Ltd.
Nancy Lockhart
Diane Loeb
Naomi Loeb
David Lofranco
Lombard Canada Ltd.
Marija Loncar
Longo Communities
Longo’s Family Charitable
Foundation
Looped for Life Golf
Tournament
Lorenzo Investment Ltd.
A.B. Lorriman
Losani Homes (1998) Ltd.
Isabel Losch
Otto & Ida Lowas
Steven and Linda Lowden
Lowe Roche Advertising Ltd.
Lucky Power Memorial
Alexander Lui
Betty Lui
Don Lunau’s Family
Tony Lundy
L’Unita Resturant Inc.
Luttrell Parker Insurance Brokers
Ltd.
LVF Management Inc.
Ngoc Ly
Lyncor Technologies
M.A.M. Group Inc.
Cheong Kou Ma
Susan Edna Maass-Robinson
Jane MacDonald
R.G. Macdonald
Eve and H. Macdougall
George MacDowell
Sheila MacFetters
MacFeeters Family Fund
Bruce and Barbara MacGowan
Jonathan Machado
Jimmy and Melissa Machado
Douglas G. MacKay
Alexander D. Mackay
Ann and Douglas Mackay
Darryl Mackenzie
William Mackenzie
William MacLaren
Maclaser Printing Inc.
Candace MacLean
Eric MacNeil
Iain Macphail
Macquarie Bank Foundation
John and Janet Madden
Magnotta Winery Estates Ltd.
Douglas W. Mahaffy
Geraldine Mahoney
Olev S. Maimets
23
Mick Majid
Kam-Kong Mak
Tak W. Mak
Andy Makowski
J. Paul and Phyllis Malette
Malfar Mechanical Inc.
Monica J. Malkus
Ida Mammone
George S. Mann
S. Paul Mantini
Marana Kitchen & Home Design
Marciano Beckenstein LLP
Emma Marin
Luciano Marino
Margaret Mark
Allan Mark
Mark Clemons Medicine
Professional Corp.
Helen and Gerald Marr
Mar-San Contractors Ltd.
Catherine A. Marsh
Marsh Canada Ltd.
Jill Denham and Stephen
Marshall
Keith and Jennifer Martin
Martin Daniel Interiors
Dave Martino
J. Scott Martyn
David Marx
Emerson Mascoll
Masdel Canada Inc.
Ewan Mason
Warren Mason
Martin A. Mason
Janice E. Masotti
MasterCard Matching Gift
Program
Matera Carpentry Contractors
Ltd.
John Matovich
Geoffrey Matus
Maureen Shaughnessy Kitts And
Associates
Maurice Joseph Weisfeld &
Louis Weisfeld Charitable
Fdn.
Christina and Joe MauroManget
Jill Maxwell
Mayfair Electric Ltd.
Maystar General Constructors
Inc.
Kenneth and Sheila McArthur
Rebecca McBride
Brad McCann
David R. McCready
Debbie McCue
Elizabeth M. McDermid
William L. McDonald
Maria and Peter McDonnell
Conor J. McDonough
John Lorn McDougall
Frances Ross Silcox McDowellw
Robert McFarland
Timothy J. McGillion
McKeller Structured Settlements
James McKenzie
Robert and Dorothy McKittrick
John McLaine
Mark McLean
Daryl McLean
Elizabeth McLean
Gordon McLean
Robyn Mcmorris
Roy and Ria McMurtry
John McNally
Medical College of Wisonsin
Laurie Melbourne
Theresa Mellis
Lisa Melo
Melody Homes
Angelo Melone
Joanne Mercer
Margaret and Bruce Mercer
Michael Meredith
Salvino Merola
Meteor Telecommunicatons Inc.
Metro Painters (2004) Ltd.
Metropolitan Plumbing
& Heating Contractors
Association
Metrus Properties II Inc.
MIA
Gabriella C. Micallef
Michael & Jackie Shulman
Family Fund
Michael Bros. Excavating
Michael Kluthe Salon
Michael La Patriello Fund at the
Toronto Community Fdn.
Michelin Group
Micro Consulting Inc.
Dan Mida
Israel H. Mida
David Miguel and Julie-Ann
Pesce
MIJO Corporaton
G. Craig Miles
Miles S. Nadal/MDC Corp.
Marc Milgrom
James and Karen Miller
Miller Thomson LLP
Cecilia M. Mills
Millwork Home Centre
Elizabeth A.Milne
Milton Oldstars
Mimico Plywood Ltd.
Mark Minden and Family
Ministry of Children & Youth
Services
Clive and Fran Minto
Florence Minz
John Miron
Peter Misener
Mister Safety Shoes
Timothy Mitchell
George Mitchell
Bruce Mitchell
Modern Niagara Toronto Inc.
Neda and Ata Moeini
Barry Monaghan
Karen and Jeffrey Moness
Monsterworldwide
Montana Steele Advertising Inc.
Montcorr Packaging Ltd.
Montecassino Hospitality Group
Inc.
Montevallo Developments Ltd.
Jeff Mooney
Gene Moore
John Moore
Malcolm Moore
Linda Moran
Morega Agency
Lino and Piera Morra
Scott Morrison
Nancy Morrison
David E. Morrison
Pat Morton
Moscone Tile Ltd.
The Moshoian Family
Darrin Moss
Mount Sinai Hospital
Gregory Paul Mountjoy
Nick J. Mourant
Orest Moysey
Ingrid Mueller
Shukla Mukherji
Mulitimed Inc.
Multiseal Paving Comany
Municipal Mechanical
Contractors Ltd.
Alice Murphy
Mur-Wall Concrete Forming
Steven Muzzo
Margaret Myatt
Myles Mindham Jewellery Ltd.
Mr. and Mrs. James Mylrea
Dalia Naami
Tony Naccarato
Laura Nadalini Bayer
Douglas and Sarah Nadherny
Community Giving
The breadth of support in the community for The Princess Margaret is truly remarkable. It is demonstrated everyday as ordinary people make extraordinary gifts through our Community Giving programs. This past year, we
had over 40,000 donors support the hospital through our annual giving and monthly giving programs. Significant
annual support was provided by 800-plus donors belonging to
Princess Margaret’s Inner Circle – the newly redesigned Leadership
Giving Society. Many more thousands of people chose to pay tribute
to someone special through the Tribute Memorial and Wedding and
Holiday Card programs. Combined, over $6.3 million was raised this
year by Community Giving.
Each gift, no matter how large or small, is essential in helping bridge
the gap between what the government funds for healthcare and
what the hospital needs and aspires to deliver to our patients. We
thank our Community Giving donors for sharing our vision, and
combining their ‘passion capital’ with their financial capital for the
benefit of our patients.
Held annually, our Donor Appreciation Tea lets donors learn more about the work of The Princess Margaret, and receive our thanks for their
generous, sustained support. We couldn’t do our work without you. Thank you!
24
Linda Nadolny-Cogan
John Nagel
Libby and Arnold Naiman
NAPG Equities Inc.
National Home
Misbah Nawaz
NBCN
Barry and Louise Needler
Stephen R. Neil
Terry Neill
Robert Neish and Kerry Tooth
Nelson Arthur Hyland
Foundation
Mary M. Nesbitt
Net Present Services
Network Site Services Ltd.
NeuLion Inc./JumpTV Inc.
New Age Homes Ltd.
New Life Mills Ltd.
Robert Newby
W. Douglas Newland and Family
Wayne N. Newling
Reta Margles Newman
Newmarket & District Associ.
For Community Living
Newways Carpentry
Marie Nichols
Jim and Brenda Nicholson
Nicholson and Cates Ltd.
Nick and Lynn Ross Charitable
Foundation
Judith M. Nicoll
Allen Nightingale
Niran Construction Ltd.
Ian V. B. Nordheimer
Normerica Inc.
Janet and Michael Norris
Joan Norris
Lesley E. North
North American Development
Group
North City General Insurance
Brokers Ltd.
North Hill Auto Service Inc.
North Star Homes Inc.
Northam Realty Advisors Ltd.
Nortown Plumbing Ltd.
Nova Services Group Inc.
Boris Novansky
Novapro Equipment Ltd.
Novx Systems Inc.
Richard Nytko
Oakdale Kitchens Inc.
Adrienne Offman
Georgina A. O’Gallagher
Makio Ogawa
Randall Oliphant
Gwen Oliver
Olon Industries Inc.
Omers Capital Partners
Oncogenex Technologies Inc.
Kathleen M. O’Neill
Ontario 2022704
On-Trac Auto & Equipment
Services Ltd.
OPG Employees’ & Pensioners’
Charity Trust
Ophthamology Consultant Staff
Association P.M.H.
Howard Orfus
Orion Hardware Corp.
Kari Osmar
Leif Ostlund
Otis Canada Inc.
P&H Foods
Sanjeev Pabbi
Prem and Bimla Pabbi
Pacific Construction Services
Christopher J. Paige
Tetra Pak
Pal Benefits Inc.
Palace Arms
G. Palazzo
Bernice Palef
James Palleschia
Panalpina Inc.
Mai Pandolfi
Panfinancial Insurance Agencies
Ltd.
Ching Pui Pang
Constantine Pangalosw
Nick and Loretta Pantaleo
In Honour of Walter B. Pape
Freda Papoff
Paradigm Capital Inc.
Paradise Homes Corp.
Paragon Secruity
James Parks
Parrish & Heimbecker Ltd.
Partners in Psychiatry
Marshal and Tina Partnoy
Graziella and Beppino Pasquali
Shilpen Patel
Sailesh Patel
Piotr Pater
Marcello and Filomena
Paternostro
Tamara Paterson
Peter Pearce
Peddle & Pollard LLP
David and Stacey Peereboom
Megan Pellijeff
Darren Pembleton
Brian Penny
Pepsico Foundation
Karen Perez
Performance Trust
Christina Pesce
Peter’s Food Shop
Angelo and Carolina Petrucci
Pfaff Porsche
Philfam Investments Inc.
Phillips, Hager & North
Investment Management Ltd.
Livany Pialis
Gianfranco G.Piccini
Piller Sausages & Delicatessens
Ltd.
Pinetree Capital Ltd.
Pink Positive
Italia Lee Pistilli
Ward and Diana Pitfield
James B. Pitts
Dominic and Marisa Pizzarelli
Plaiter Place
Andy Plata
Donald Plummer
Murray H. Pollitt
Polytarp Products
Francis Pope
Port Royal Mills Ltd.
Jean Charles Potvin and Lucie
Marion
M. Hope Powell
Michael Power
Courtney Pratt
Maurice and Donna Preston
Frances Price
PricewaterhouseCoopers
Mary and Erik Prieditis
Prime “R” Management Inc.
Primo Mechanical Inc.
Andrew and Valerie Pringle
Priority Brands
Private Giving Foundation
Pro Con Building Supplies Ltd.
Project Cure Paola’s Fund
Promenade Park Ltd.
Protects Lock & Alarm Inc.
Heather Pultz
Pure Staffing Solutions Inc.
Fred and Catherine Purvis
Quality Custom Blending Ltd.
Quality Rugs of Canada Ltd.
Queen Post Properties Inc.
Elizabeth H. Quembyw
Quest Window Systems Inc.
Jeannine Raab
Anton and Ilana Rabie
David H. Race
Elaine and Don Rafelman
Oskar Rajsky
Michael Rak
Suman Rakhit
Rapini’s Ristorante Ltd.
Ras-Con Inc.
Ratech Electronics Ltd. In
Honour of Frank A. Rago
Abbe Raven
Ravenshoe Group
Robert S. Rawlings
Raylan Electrical Systems
RBC Financial Group
RBI International
RCC Group Inc.
Reactive Mortgages
Margaret May Elizabeth Readw
Ready Bake Foods Inc.
Deena Reale
William Henry Reid
Margaret W. Reid
William G.Reid
John Reilly
Irene Reingold
Reitmans (Canada) Ltd.
Resform Construction Ltd.
Reuven International Ltd.
Dirk and Anne Reyneveld
RGK Construction Managment
Inc.
Antonio Ribeiro
Sonla Ricci
Richard Gambin RDQ
Richardson, Tatangelo LLP
Riedel Crystal of Canada
Rigobon Carli
RioCan
Barb and Ced Ritchie
Jo-Ann E. Ritchie
Rivervalley Masonry Group Ltd.
Roadside Paving
Robert Warehouse (GRM)
Shauna Robertson
Lloyd J. Robertson
Andrew Robins
Robins Appleby Charitable
Foundation
Kathryn Robinson
Robert John Robinsonw
Tim Roden
Rogers Group of Companies
Dhanieran Rohit
Pierre Rolin
Adolph Rolin
Mary and Michael Rolland
Katherine and Frank Rolph
Roman Metal Fabricating Ltd.
Angela Romita
Sue Rooks
Annie Ropar
Giuseppe Rosati
Harry Rosew
Cory Rosen
Family and Friends of Ethel
Rosen
Ronald Rosenthal
Joseph Rosenthal
Sandy A. Ross
Nancy Ross
David Ross
Lynda Ann Rosser
Brian and Alida Rossy
Ronda Roth
Rolando Roti
Jill Rowan
J. Rowe
Brad Rowse
Roy Turk Industrial Sales
Royal LePage
Royal Trust Company
Morley and Rifka Rubinoff
Ron and Rochelle Rubinoff
Adam Rubinoff
Ruland Realty Ltd.
Jeane Velma Rumble
Celia Rumm
David Rumpel
Runners Choice Promotions/
RCP International
Ruth Russellw
Rustique Home Furnishings Inc.
RYESAC Student Groups
S & C Electric Canada Ltd.
S Chum Torno Fund
S.C. Land Management Corp.
S.O. Asher Consultants Ltd.
Giorgio Sabatini
Saberwood Homes
Nick Sacchetti
Susan Sacchi
Nadir Sachak
Saddlebrook Management
Consult Inc.
Michael Sadiwnyk
Andrei Sadu
Saint Dunstan of Canterbury
(Anglican Church of Canada)
Sally’s Friends at HP
Saltsov Holdings Inc.
25
Sanctuary International Day
Spas
Samanta Sandler
Stephen and Cookie Sandler
Mary Lou Santaguida
Antonio Santoro
Tony Santoro
Allen Sapp
Sara Campos Leal Fundraising
Andrea Sass-Kortsak
Ernie Saveriano
Robert Savignac
Barry Sawyer
Colin Bernard Scarfew
Schawk Canada Inc.
Ron and Irene Schelfhaut
Schering Canada Inc.
Rolf Schoene
Paula Schonberger
Garry and Mariena Schroeder
Karl A. Schulz
Alan Schwarz
Charles and Mina Schwarz
SciCan
Scotia Mcleod
SCRAS
Adriano Scurci
Diana and Paul Sealy
Sears Canada Inc.
Segal Communications Inc.
Senang Investments Ltd.
Sequoia Grove Homes Inc.
Service Results Technology Inc.
Peter Seto
Shadowcorp Investments Ltd.
Pat and Skip Shand
Ashish Sharma
Lydia Sharpe
L. Peter Sharpe
Brian and Margaret Shaw
Neil Shaw
Virginia Shaw
Shaw-Almex Industries Ltd.
Shaw’s Plumbing & Heating
T. Gerry and Patricia Sheehan
Sheet Metal Workers
International Association
Shell Canada Products
Sheridan Nurseries Ltd.
Henry and Gloria Shewchuk
Owen Shime
Shimmerman Penn LLP
Shipman Electric Ltd.
Christopher Shippen
Naju B. Shroff
Esther Shubw
Florence and Al Silver
Silver Carpentry
Geoff Silverberg
Sid and Sue Silverberg and
Family
Margaret and Robert Sim
Ivor Simmons
Simmons & Assoc. Ltd.
John and Hedy Simonyi
Simply Gorgeous Ltd.
Brenda Simpson
Lawrence Sinclair
Dominic Siniscalco
Linda Sky Grossman
26
Sky Homes Corp.
SL Nature Fiber Inc.
Jan M. Slaight
Effie Slapnicar
Paul and Carol Slavens
Slavens & Associates Real Estate
Inc.
Faida Smale
Smart Centres
Thomas Smith
Terry Smith
Peter Smith
Nigel Smith
Jacqueline and Scott Snarr
Ralph and Danny Soberano and
Family
Sofina Foods Inc.
Mary Soler
Solmar Development Corp.
Henry Solow
Alim Somani
Somerville National Leasing &
Rentals Ltd.
Sony Computer Entertainment
Canada
Joseph Sorbara
Nick Sostarich
Special Essentials Inc.
Spectrum Healthcare
Spectrum Realty
Marion and Don Spencer
Stephen D. Sperling
Jeff Spinks
Spring Town Homes
Sprucewood Shores
G. Wayne Squibb
Madeline and Joseph Srebot
Hindupuram Sriharsha
St. Elizabeth Catholic High
School
Helen Allen Staceyw
Standard Securities Capital
Star Plaster Inc.
Starfield Lion
Helen Stark
Ken Stathakis - The Octagon
Restaurant
Chris Stavro
Louis Stavropoulos
Steel Canada Ltd.
Richard Harris Steelew
Gaye and Andy Stein
Ronald S. Steinberg, Paula
Brockman and Susan Caplan
Joseph and Elaine Steiner
Victoria Steir
Bonnie Stephen
Stephen Bourassa Chiropractic
Professional Corporaion
Sterling Group of Funds
Sterling Growth Corp
Sterling Packers Ltd.
Sterling Tile
Ruth Sternberg
Stevenson & Hunt
Lauretta D. Stewart
Joan M. Stewart
Morag L. Stewart
Michael Stock
Stone Tile International Inc.
Ellen Storfer
Strategic Charitable Giving
Foundation
Nick Stratos
Louis Strauss
Elsa and Ted Stringer
Marianne Strobele
Strolf Rehab
James E. D. Stuart
Paul Sudolski
Barbara and Harvey Sugar
Summer Berry Homes Inc.
Sun Life Financial
Sunfield Homes (Waterdown)
Ltd.
Sussex Strategy Group Inc.
Martin Sversky
Sydney and Florence Cooper
and Family
Scott Syrja
Robert Taberner
Nabil Tabel
Vaclav Taborsky
TACC Construction Ltd.
Mohamed Tahir
Kar Kin Tai
Talon Systems Inc.
Ronald Peter Tam
Tam Electric
Tamarack Lumber Inc.
Lawrence and Judith
Tanenbaum
Remembering sister Mary Tasker
Edward Taylor
Joan Taylor
Lee Taylor
TD Bank Financial Group
TD Waterhouse Private Client
Services
TDE International
Technicore Underground Inc.
Teknion Form Inc.
TELUS
Marianne Teminski
Tenen Investments Ltd.
Terrasan Envirnomental
Solutions
Tesari Charitable Foundation
Grace Tevlin
The Acorn Development
Corporate
The Atlas Corp.
The B.A. Himel Family
Foundation
The Bank of Nova Scotia Trust
Company
The Beer Store
The Behar Group Realty Inc.
The Benjamin Group
The Bradstreet Family
Foundation
The Buchan Family Foundation
The Car Company of Canada
The Charitable Gift Funds
Canada Foundation
The David & Luba Smuschkowitz
Family Charitable Foundation
James L. Thomsonw
The Etobicoke Church of God
(Seventh Day) Charity
The Frances Tanenbaum
The Gary Warner Memorial Golf
Tournment
The George & Kay Goldlist
Foundation
The Herbert Green Family
Charitable Foundation Inc.
The Ice Men
The Kaitlin Group Ltd.
The Kay Family Charitable
Foundation
The Lakeview/Montemarano
The Lawrence & Frances
Bloomberg Foundation
The Leonard & Felicie Blatt
Foundation
The Les and Minda Feldman
The Litho Colour Services
The Margaret Ann and Donald
S. McGiverin Foundation
The Marilyn Van Stone
Foundation
The Martin Family
The Mayvon Foundation
The Midas Investment Corp.
The Morty Frank Memorial Fund
Inc.
The Oak Stair Ltd.
The Pears Foundation
The Phelps Group Inc.
The Philip Smith Foundation
The Rogan Foundation
The Royal Canadian Legion
General Wingate Branch 256
The Royal Victoria Hospital of
Barrie
The Rubinet Faucet Co Ltd.
The Schumacher Family
Foundation
The Sherry and Sean Bourne
The Sign of The Skier
The Sonshine Family
Foundation
The Taylor Group
The Torgan Group
The Toronto Wholesale Produce
Association
The Walker Lynch Foundation
The Weisz Family Foundation
The William and Anita Newman
Foundation
The Young Family Foundation
Nevil and Susanne Thomas
Terry and Carole Thompson
Douglas Thompson
Thompson, Roach & Hughes
Consulting Inc.
Thelma Thomson
Thorncrete Construction Ltd.
Richard Thorpe
ThyssenKrupp Elevator (Canada)
Ltd.
Tice River Estates Inc.
Tides Canada Foundation
TierOne OSS Technologies Inc.
Tiffany & Co.
Tinistar Co.
Sandra Title
Tobe Family Foundation
Toddglen Services Ltd.
Tolin Enterprises Ltd.
A. K. Tomasik
Tom’s Place
Tonolli Canada Ltd.
David Topper
Tor-Con Construction Co.
Philip Tornow
Toro Aluminum
Robert Torokvei
Toronto East General Hospital
Foundation
Toronto Firefighters Association
Toronto Hospital Urology
Associates
Toronto Rock Lacrosse Club
Zoltan Toth
Peter G. Townley
Townwood Homes Inc.
Train Trailer Rentals Ltd.
Thu Tran
Transamerica Life Canada
Transcanada Pipelines
Transcore Link Logistics Corp.
Transportaction Lease Systems
Inc.
Travelers Guarantee Company
of Canada
Traynor’s Bakery Wholesale Ltd.
Rae Tregunna
Sandra Trehub
Trend Line Marketing Inc.
Trevcor Management Inc.
Trican Masonry Contractors Inc.
Tricon Capital Group Inc.
Tridel Corp.
Greg Trieloff
Trimap Communications Inc.
Nga My Trinh
Trinity Plastic Products Inc.
Trio Capital
Tropical Insulation Inc.
Gabriel T. Tsampalieros
Alice F. K. Tse
Leagh Turner
twenty6two
Tyco Electronics Canada Ltd.
Cam Ubell
Archie Ublansky
UBS
ULC
Lawrence and Anne Ullman
Sok Teang Ung
Uniboard Canada Inc.
Unitec York Inc.
Universal Studios Canada Inc.
University of Toronto Press Inc.
University Plumbing & Heating
Ltd.
Upper Canada College
Upper Canada Soap & Candle
Makers
Hazelton Men
Mirali Vaez
Vito Valela
Nancy Valenza
Tiziana Valeri-Debenedictis
Charles Vallance
Valle Pligna Socio-Cultural
Association
Valleymede Building AMA Corp.
Timothy Van Alstyne
Vantage Insulation Ltd.
Varian Medical Systems
Varicent Software
Vaughan Irrigation
Shirlee Vedder
Herbert Veisman
Sabine Veit
Venetor Equipment Rental Inc.
Veritas Communications Inc.
Almas and Zul Verjee
Yvonne Vetere
Viewmark Homes Ltd.
Village Masonry Construction
Inc.
Pat and Sandra Villani
Brenda J. Vince
Vincent Salvatore Family Trust
Vitaid Ltd.
Anna and Brent Voetmann
Michael Volpatti
Volpe Paper Fibers Inc.
Robert and Marlene von der
Porten
Elaine Waisglass and Michael
Hirsh
Carolyn Kent Waitew
Jeff Walderman
Lionel and Sandra Waldman and
Family
Mark and Elana Waldman
Brian Walker
Peter and Kimberlee Wallace
Ruvan P. Waltman
Michael C. Ward
Padraig and Marian Warde
Sinclair Wardrop
Warnaco of Canada Company
John Warwick
Joye Waterhouse
The Wateman Family
Marjorie V. Waters
Phyllis and William Waters
Ron Waters
John and Josie Watson
Wayne Cassidy & Co.
John Weatherall
Morris Weber
Wedlock Paper Converters Ltd.
Graham and Judith Weeks
Lucy Weinstein
John G. Weir
Susan Weisbarth
Robert and Suzanne Weiss
Eric Weisz
Margaret Weisz
Catherine Welfe
Marion Jean Wellwood
Richard Wengle
West End Interior Inc.
Brigitte Westaway
William W. Westcott
Weston Flooring Ltd.
Weston Premium Woods Inc.
Westpalm Development Corp.
Westside Studio
Whispa Co. Ltd.
Brad White
Alden White
William White
Margaret D. Whitfield
Carl D. Whitten
Joe A. Wightman
Jennie I. Wildridge
David and June Williams
Christopher and Georgiann
Wills
Edna Wilson
Thomas Wilson
W. H. Wilson
D. Jean Wilson
Margaret Wilson
Richard B. Wilson
Scott A. Wilson
Shelagh E. Wilson
Florence Kathleen Wilsonw
Mary I. Wilsonw
WilsonArt Canada
Judith and Jack Winberg
Paul K. Wing
Howard Wise
Lynda Wise
Fern and Herb Wisebrod
Jack and Nan Wiseman
Ian Witterick
Harland Wittick
David and Mary Wolf
Chor Yin Wong
Lea-Choung Wong
Angela M.Y. Wong
Frank Wong
Isabella Shuk Ling Wong
Kan Sum Wong
Shun Wong
Woodbridge Foam Corp.
Woodbridge Lumber Inc.
Tony Woodward
Sylvia and Irving Wortsman
Elizabeth Wright
WSI
Wyeth Consumers Healthcare
Inc.
Wyeth Pharmaceuticals
Dugald Wylie
Mitchell Wywiorski
Y. Onyschuk & Co. Ltd.
Minnie Yack
Yard Sale for the Cure
Marlene G. Yaworski
Una Yen
Yolles Partnership Inc.
York Major Holdings Inc.
York Marble Tile & Terrazzo Inc.
York University Foundation
Marina Yoshida
Lori Young
Stella Yusko
Barry, Ian and Felicia Zagdanski
Families
Barry Zakelman
Ralph Zarboni
Barry Zekelman
Zentil Property Management
Inc.
Jason Zerafa
Zetra Enterprises Inc.
Dov and Caroline Zevy
Ron Zevy
Helen Zinkargue
Eric Zoebelein
Zoran Real Estate Ltd.
Sharon Zuckerman
Helen Zukerman
We are very grateful to the following firms who have generously donated their skills, products and materials.
92.5 JACK FM
97.3 EZ Rock
98.1 CHFI
104.5 CHUM FM
680News
ACLC
Air Canada Vacations
Astral Media Inc.
Barefoot Wine
BBQ Gourmet
Birks and Mayors
BNN (Business News
Network)
Boisset Canada
Canadian House and
Home
Canwest Global
Communications
CBC
CIBC
Citytv
CFRB
Classical 96.3FM
Clean Sheet
Coca-Cola Bottling
Colgate
CTV
Daniels Corp.
EastDell Estate Winery
Fandor Homes
Ford Canada
Greenpark Homes
Hansen Construction
Heenan Blaikie
IBM
IMA
Intrawest
Kaitlin Group
Kraft Canada
Linwood Homes
MAD
marketing+design
McWhirter and
Associates
Merit Vacations
Muskoka Building Co.
Naked Creative
OMNI Television
Pattison Outdoor
Pepsi / Frito-Lay
Q107
Resolve Corp.
Rogers TV
Sassafraz Restaurant
Six Degrees Medical
Consulting
Slaight
Communications
Sobeys
Steam Whistle
Brewery
Swiss Chalet Rotisserie
& Grill
Sun TV
Sunquest Vacations
SuperClubs Breezes
Resorts
The Globe and Mail
The National Post
The Toronto Star
The New Country
95.3 FM
TLN
Toronto Sun
VIA Rail Canada
Y&R
Yuk Yuk’s
27
JCB Grant Society Members
Membership in the JCB Grant Society is offered to donors who have included The Princess Margaret Hospital
Foundation in their will or have made a future or life income gift. These special friends of the Foundation have made
the fight to conquer cancer in our lifetime part of their own personal legacy.
The JCB Grant Society is named after the distinguished Toronto professor of anatomy, Dr. J.C. Boileau Grant, the
author of Grant’s Atlas of Anatomy. Princess Margaret Hospital has a special connection with Dr. Grant. His widow,
Anne Catriona Robertson, left us a bequest of the Atlas when she died in 1982. With the annual royalty payments,
The Princess Margaret Hospital Foundation has created the JCB Grant Chair in Oncologic Pathology, a $2.2 million
endowed chair, as well as a major named endowment fund.
The Grant family’s example is important to us: they have left an important legacy with a creative gift, and they have
improved our ability to conduct leading-edge cancer research. Through the JCB Grant Society, we pay tribute both to
the Grant family and to each donor who has confirmed a planned gift to The Princess Margaret.
Violet Adair
Scarlat Albright
Bruce Alexandor
Omar Ali
The Alofs Family
Keith Ambachtsheer and
Virginia Atkin
Loretta and Etienne Amestoy
Roger Andersen
Shirley Arnold
Norman K. Ashurst
William Badke
Wilbur N. Baily
Jan H. Balledux
Katharine E. Barilla
Yee Y. Bell
Francesco Benichasa
Roslyn and Bernard Bennett
Shirley Bennett
Beulah Besharah
Rita Bette
Aruna Bhatnager
Rosa Bianca
Catherine Blackburn
Dorothea and Philip Bloom
Frank Bosco
Robindra N. Bose
Olive Boudreau
Geoffrey Boyes
Mary Brandon
Harold and Fredelle Brief
Beverley A. Briggs
Rob Bristow
William and Gail Brown
Ruth M. Buchanan
Joan and Jack Burkholder
Reta Burrows
David and Paula Butterfield
Laura and Sven Byl
Donald R. Cade
Fausto Carbone
Gail Carman and Dave
Hollingworth
Dorothy Carr
Christopher A. Carson
28
Eleanor G. Chapman
Margaret E. Chapman
Paul Chen
K. Carol Christian
Joyce K. Chung
Valerie and James Clark
Anne Clements
Julie A. Colosimo
Luciano and Paola Colozza
Antonio Crescenzi
Janice S. Crichton
Barry Crookes
Irene Crowe
Beryl Cruse
Enola Czech
Fern Daiter
Julie Davis
Jean Davison
Mary Dawkins
Joyce H. Denyer
Tim Devlin
Joseph Di Geso
Daniela Di Gianomasso
Wilson G. Dow
Jessie L. Dowling
Maurice Drieu
Diane Drotos
Joao J. Dutra
Linda Ecclestone
Naomi Eisenberg
Margaret Ellis
Leola English
Audrey Ennis
Margaret A. Evered
Patricia Ewart-McLean
Roy A. and Elizabeth J. Fawcett
Madeline Fielding
Leland J. Fisher
Patricia K. Ford
Josie, Jeanne and Archie
Forsyth
Jake E. Fowell
Sandra J. Frost
Larry and Eileen Fryer
Michelle Fuss
Anthony Fyles
Kathy Gallivan
Monica L. Gaudry
Marilyn Gazey
Harry and Joyce Gibbard
Ian Gibbard
Shirley Goldenberg
Lillian Gordon
Ethel Gorlick
In Honour of Beryl Elizabeth
Trimming-Green
Carol Greenwood
Christopher G. Guest
Cathy Hale
Elizabeth D. Hamilton
Doris Hansen
Helen Phebe Hatton
Sharyl Haynes
Lenard Haywood
Suzanne Hearn
Robert I. Hendy
Grant Hern
Mildred Herzog
Joan Hickey
Barbara Hill
Timen Ho and Jessie Ho
Frances M. Holland
A. D. Holt
Joan Pui-Ying Hosang
Margaret J.H. Howitt
Dr. Huie
Peter and Dalit Hume
Glenn Hunnings
Jeannine Hutty
Nicholas B. Imming
Tommasino-Timpano Iozzo
Joan I. Jackson
Simon L. Jackson
Margaret Jenkins
Agnes Jenkinson
Nancy Jennings
Elspeth A. Johnson
Fran Johnston
Barry Jones
Lee-Anne Kant
Jeff Karl
Diane Karnay and Stuart Bollefer
Carla Keel
Grace Kelly
Nora Kent
Kathryn Kernohan
Andrea Kinch
Neville and Lorraine Kirchmann
Paula Kirsh
Veronica Kollar
Selwyn and Pippa Kossuth
Sherry Kou
Margaret, Audrey and James
Laidler
Harold Lane
Colin Languedoc
Jocelyne Laniel
James and Moira Lawrence
Barry Lebow
Joan and Bob Lehman
Kathleen D. Leslie
Charles E. Letman
Daniel Lichtman
Meryl Lindale
Irene M. Lloyd
Audrey Loeb and David Ross
Margaret Jane Logan
Marija Loncar
Maria Loschiavo
Rita Louidor
Charles MacAllister
John Macdonald
Mr. and Mrs. John D. Mackay
William MacLaren
John and Gail MacNaughton
June Mansfield
John C. Marshall
Robert Martin
Frances I. Masefield Acheson
Antonio and Seli Masegosa
Dana Maslic
Aureade Massey
Jean Matlow
Doris McCartney
Joyce L. McCathie
Janice McDonald
R.A. Guy McGuire
William George McIntyre
Elizabeth McLean
Kenneth A. McLean
Paul McNab and Mary CollinsMcNab
Beverly McRae
Elizabeth Meldrum
Louis Michael
Rosa Milano
Barbara Jean Miles
George Miljevich
James Miller
Patricia Miller
Ruth M. Miller
S. Milne
Rita and Gerald Misner
John K. Mitchell
Lois Mitchell
Carla Monk
Doris J. Moore
Harold A. Morden
Eleanor Morgan
Brad Morris
Carol Morrison
Miriam Mozes
June Murdoch
Freda A. Muscovitch
Margaret and William Myers
Jill and Reed Nelson
Susan Newman
Doris Noftall
Priscilla Ralph-Norris
Pamela and Donald North
Aimee M. O’Connor
Manuel Oliveira
Galina Ozols
Marshal and Tina Partnoy
John Patterson
Colleen Peacock
Brian Pecic
Constance Peters
Stan and Helen Petrowski
Robert L. Pidgeon
Gertrude Piggot
Margaret Pollard
Sofia Polyanovsky
Margaret Porteous
Mary E. Porter
Karen M. Potter
M. Hope Powell
Clare Price
Eleanor Pridham
Hilda Pruuli
Linda Puma
Abel Quintal
Robert S. Rawlings
Bernie Rees
Florence Reilly
John Reilly
Gladys Rennie
Edna Reynolds
Heather Richardson
Lionel and Helaine Robins
Charles H. and Kathleen A.
Robinson
Betty Ross
Annice H. Rothbart
Coleman Rotstein
Ross and Gwenda Roxburgh
Therese Roy
Marci J. Rubinoff
Barbara E. Russell
Ruth E. Russell
Patricia Sauerbrei
James H. (Bert) Scott
Frank and Red Selke
Idola G. Semple
Anne Shanahan
Naju B. Shroff and Keki B. Shroff
Antonio Sicilia
Margaret Simmons
Graham T. Skells
Linda Sky Grossman
Sheila Smith
Thomas Smith
Helen Stark
Annabelle Stephens
D. Eleanor Stephenson
Ian Stobart
Elsa and Ted Stringer
Shannon and Micheal Stuart
Ann D. Sutton
Dorothy Sutton
Jean Swanson
Richard F. Tayler
Tina Tehranchian
Helen Tennyson
Irmgard Theegarten
Gai Thomas
Nelson Tilander
Frederick Tiley
Joan Tilt
June and Joseph M. Tkach
Mildred Trachtenberg
Jerry Trestik
Jackie Tuffin
Pat Nichols and Bob
Tundermann
Belal Uddin
John and Tess Van Netten
Joseph Vannot
Lou Vigoda
Nancy J. Vivian
John Paul Watman
Lisa L. Weaver
Sophie Weimert
Vanessa Wellwood
Lawrence Wert
Hazel Westlake
Mary E. Whitaker
Clyde Shepard Whitham
Linda Whyte
Charles T. Wilson
Debra Wilson
Sharon Wilson
Mary Winter
Jonathon Wisebrod
Susan McLean Woodburn
Donald and Janice Woodley
Ethel M. Woods
Betsy Wright
William A. Wright
Donald A. Wylie
Morden S. Yolles
Ginette Young
Chung-Fu Yu
Valentina Zatskoy Loper
She Never Stopped Reminding her Patients to Floss, Floss, Floss!
Dr. Lucie Tuch kept her dental patients informed of her cancer journey through a
series of letters filled with her concern for them, her courage and determination to
fight the cancer, and, most of all, her delightful sense of humour. She was devoted
to her dental practice and had difficulty giving it up—even to her sister—when she
was forced to focus on her health and cancer treatment.
She adored the CBC, and talked about her great propensity for remembering the
“little ditties” accompanying the old radio advertisements like Brylcreem, Ivory
Snow and Dodd’s Little Kidney Pills.
Lucie left instructions in her Will for her Executor (her husband Egon) to make
charitable gifts on her behalf. After consulting with the Foundation to discuss
an appropriate and meaningful way to pay tribute to his wonderful wife, Egon
Homburger chose to make a generous gift in her name to the dental clinic of
Princess Margaret Hospital. The gift was used to purchase a digital panoramic
dental X-ray machine which allows the clinic to operate much more efficiently, with
less processing chemistry (less pollution), and to save on physical storage space.
29
Named Expendable Funds
ABC Group Donation Fund
ABC Group Inc. Ambulatory Infusion Pump Fund
Abraxis BioScience Fellowship Fund
Adelson Foundation Fund for Ovarian Cancer
Research
Agnico-Eagle Research Fund
Al Hertz Centre for Supportive and Palliative Care
Fund
Allan Kerbel Trust Fund
Alli’s Journey Fund
Amelia Plastina Breast Cancer Research and
Equipment Fund
Ann and Irving Storfer Lymphoma Research Fund
Anna-Liisa Farquharson Kidney Cancer Research
Fund
Asaro Family Lymphoma Fellowship Fund
Ask Ethel Fund
Barrie Rose Fund
Barry and Susanne Cooper Family Fund
Ben and Hilda Katz Charitable Foundation Fund
Bette Johnston Cooperative Student Scholarship
Fund
Betty Mendelssohn Kalmanasch Medical Research
Fund
Betty Meretsky Patient Care Fund
Blaine Richard Stein Fund
Bram Appel Fund for Molecular Diagnostics in
Ovarian Cancer
Bras Family New Drug Development Program Fund
Brian Ellies Esophageal Cancer Prevention Fund
Brian Pendleton and Chad Goldman Ovarian Cancer
Fund
Bruce Galloway Fund in Head and Neck Cancer
Research
Bush International Fellowship Fund
Campbell Family Institute for Breast Cancer
Research Fund
Canadian Conference of Asbestos Workers Fund
Cancer Biobank Core Laboratory Fund
Carmel Derdaele Breast Cancer Research Fund
Charles and Marilyn Gold Family Foundation Fund
Charles Krowitz Burkitt’s Lymphoma Research Fund
Concetta Guglietti Most Wanted Fund for
Gynecological Cancer
Cure for Lung Cancer Team Fund
Daniel Alan Sheehan Brain Tumour Research Fund
Daniel Roncari Prostate Cancer Research Fund
Daryl Rubinoff Fund
David and June Anne Melnik Prostate Patient
Support Fund
David and Paula Butterfield Ovarian Cancer
Database Fund
David and Sharon Aello Skull Base Fund
David Cornfield Melanoma Research Fund
Derek Russell Fund for Clinical Trials Nursing
Desmond and Pamela O’Rorke Drug Development
Fund
Diane Lanthier Nursing Care Fund
Dick Aldridge Pancreatic Cancer Research Fund
Domenic Dell’Elce Fund
Donald J. Young Fund
Donati Family - St. Michael’s Majors Ovarian Cancer
Fund
Dr. Addleman Memorial Lecture Fund
Dr. Annie Smith Bear Fund for Ovarian Cancer
Dr. Geoffrey R. Conway Chemotherapy Fund
Dr. J. Bacher Golf Tournament Fund
Edie and Eric Yolles Cell Therapy Research Fund
Elana Waldman Fund
Elizabeth M. Walter Fund
Elsa and Ted Stringer Fund
30
Estelle Craig Family Fund
Eve Corrigan Cancer Research Fund
Fire Fighters’ Cancer Research Fund
Frank A. Ragona Fund
Freed Family Fund
Friends for Life Fund
Friuli Cancer Research Academic Exchange Program
Fund
Gadler, Lam, Pellegrino Palliative Care Fund
Gattuso Rapid Diagnostic Centre Fund
General Electric Canada Inc. Fund
George A. Cohon Fund for Reconstructive Surgery
for Prostate Cancer
Gerald and Paula Kirsh Family Fund
Gerald M. Soloway Prostate Cancer Research Fund
Gerald Siegel Fund for Pancreatic Cancer Research
Gerry & Nancy Pencer Brain Trust Fund
Gerry Ruby Fund
Gift of Life Fund
Gift of Love (G.O.L.F.) Fund
Giovanni and Concetta Guglietti Family Cancer
Fund
Goldie Risenman Fund
Gordon F. Mutch Fund
Gordon Tozer Head and Neck Cancer Bio-Clinical
Anthology Fund
Greenberg-Ritchie Fund
Greenpark Blood Transfusion Unit Fund
Gucciardi Family Fund for Cell Therapy
Harley Ulster and Cindy Leder Multiple Myeloma
Research Fund
Harold Niman Prostate Research Fund
Harry Littler Cancer Research Fund
Hatch Family Fund
Helen and Irving Davis Fund
Hibiscus Fund for Hope
Hillary Firestone Ovarian Cancer Research Fund
Hogarth Family Foundation Fund for Brachytherapy
Research
Ian and Anne Devine Fund
Ian Lawson Van Toch Cancer Informatics Fund
Ice Sports Centre Etobicoke Tournament Fund
Ida Rubinoff Patient Support Fund
Imperial Oil Foundation Mesothelioma Research
Fund
Isabel Koffman Fund for Pancreatic Cancer Research
J. David and Jan Crichton Fund
J. Richard and Dorothy Shiff Fund
Jack and Esther Cole and Family Prostate Centre
Fund
Jack and Rose Wine Leukemia Research Fund
Jack Elie Memorial Tournament Fund
Jack Weinbaum Prostate Prevention Fund
Jacqueline Seroussi Foundation Fund
James Kinnear Fund
Jane and Peter Eby Fund
Janet Rosen Fund
Jennifer Evanshen Fund
Joe’s Team Fund for Translational Research
John Finlay Oncology Fund
John Fortney Party Fund
John L. Hickey Fund
John Steinberg Fund
Joseph H.M. Wood Chemotherapy Research Fund
June Anne and David Melnik Breast Cancer
Research Fund
Karen Morton Fund
Laugh Lines Fund
Laura Kathleen Gray Research Fund
Lee China Exchange Fund
Levelling the Playing Field Fund
Libby and Michael Goldgrub Gynecological Cancer
Research Fund
Lily Silver Magic Castle Fund
Linda and Marvin Barnett Fund
Lisa Coristine Brave Heart Fund
Lousie Khalatbari Nozari Fund
Lucky Power Memorial Fund
Lusi Wong Lung Cancer Early Detection Research
Fund
Marie Thompson Fund
Marilyn Barker Paulson Fund for Children with Brain
Cancer
Marilyn Green Melanoma Research Fund
Marilyn Ricci Cancer Pain Control Fund
Marilyn Van Stone Foundation Fund
Mary Hooey Education Fund
Master Insulators Association of Ontario Inc. Fund
Max Tanenbaum Garden Fund
Max Tanenbaum Sculpture Garden Fund
McDermott Patient Education Fund
Menkes Family Innovation Fund in Thoracic Surgical
Oncology
Merrill Lynch Fund
Michael Albert Garron Fund
Michael J. Dickinson Endoscopic Equipment Fund
Michael Ryan Leal Fund
Michael Wise Memorial Fund
Mona Garbuz Memorial Fund for Melanoma
Research
Muzzo Family Minimally Invasive Surgical Oncology
Program Fund
Muzzo Family Robotics Program Fund
Nadi Meir Fund
Nathan and Sara Goldlist and Family Fund
Nora Rudnick Ovarian Cancer Research Fund
Opthalmology Leslie Estate Fund
Palliative Pacers Fund
Pamela Mary Hosang Ovarian Cancer Research Fund
Paolo Ardizzi Bone Marrow Transplant Fund
Patricia J. Myhal Pancreatic Cancer Research Fund
Patrick Avison Memorial Fund
Patrick Moore Leukemia Research Fund
Paul and Rhonda Krandel Fund
Pearl Banks Fellowship in Melanoma Research and
Patient Care Fund
Penny Benjamin Fund for Caregiver Relief
Philip Mincer Fund
Philip Orsino Cell Therapy Translational Research
Fund
Phyllis Hantho Breast Cancer Research Fund
Pollen/Reinholdt Fund for Cancer Research
Posluns Family Fund
Project Cure Paola’s Fund
Pusateri’s Adult After Care Fund
R. M. Saggar Fund
Race Against Cancer Fund
Ralph Fisher Fund
Rebecca’s Hope Leukemia Research Fund
Richard Wookey Prostate Cancer Research Fund
Robert V. Brady Award Fund
Roche Fellowship in Drug Development
Ronald Buick Symposium Fund
Ronald Dunn and Ingrid Gadsden Fund for the
Benefit of Nurses on 14A
RSM Richter Breast Cancer Research Fund
Samuel Family Foundation CT/PET Centre Research
Fund
Samuel Manu-Tech Inc. Fund
Sandra Foyston Patient Education Fund
Sanofi-Aventis Fellowship Program Fund
Sara Ferlito Fund
Shirley Auslander Peace Angel Fund
Slavens Family Fund
Spin 180 Ovarian Cancer Research Fund
Spring Fund in Honour of Frank and Brenda Spring
Stephen Duviner Pancreatic Cancer Research Fund
Steven Hoffman Fellowship in Molecular Genomics
Expendable Fund
Sue Bristow Leukemia Fund
Suncor/Sunoco Gynecologic Oncology Fund
Susan Grange Advanced Simulation Program Fund
Tara Fund
Taylor Family Patient Education Fund
The Al Hertz Urgent Care Facility Fund
The Alofs Family Fund
The Beckie Fund for Breast Cancer Research
The Lo Family Fund for Leukemia Research
The Lyon Share Contribution Fund
The Michele Temple Melanoma Research Fund
The Nicole Nardi Fund
The Philip Lavorgna Life Over Lymphoma Fund
THE QUILT Breast Cancer Survivorship Fund
The RACH Fund
The Zoe Springer Memorial Fund
Tito and Maria Sansalone Fund
Toronto Fashion Show Fund
Vera Frantisak Fund
Wharton Fund for Head and Neck Cancer Research
Yasmin Bhaluani Ovarian Cancer Fund
Named Endowed Funds
Those Supporting Programs
Robert and Maggie Bras and Family New Drug
Development Program
Those Supporting Chairs
Please see page 32 for a complete listing of Chairs
Those Supporting Professorships
Bergsagel Visiting Professorship Fund
Helen M. Cooke Professorship Fund
Those Supporting Fellowships
Al Hertz Family Foundation Fund
Asaro Family Lymphoma Fellowship
Edith Kirchmann Fellowship
George Knudson Memorial Fellowship
Gerald and Sheila Hatch Fellowship
Helena Lam Fellowship in Cancer Research
Michael V. and Wanda Plachta Fellowship
Mildred Goldberg Fellowship
N. B. Keevil Fellowship in Translational Research
Oberlander Fellowship in Lung Cancer Research
Steven Hoffman Fellowship in Molecular Genomics
Those Supporting Lectureships
Bierstock Family Lectureship in Prostate Cancer
Douglas Bryce Education and Research Fund
Dr. Clifford Ash Lecture
Drs. Vera Peters and R.S. Bush Lecture in Radiation
Oncology
E.A. McCulloch Lectureship
Jeremy A. Oliver Palliative Care Endowment Fund
Philippa Harris Annual Lecture
Richard H. Grimm Lectureship in Head and Neck
Oncology
Wharton Lectureship in Head and Neck Cancer
Those Supporting Awards and Prizes
Abate Radiation Therapy Prize Fund
Fritz Spiess Research Award Fund
Gerald Kirsh Humanitarian Award Fund
Harold E. Johns Research Prize Fund
Robert G. Matthews Cancer Research and Education
Fund
The Rabbi Joseph and Doris Kanner Fund
Those Supporting Cancer Research
Abraham, Ethel and Jackie Richmond Research
Fund
Adele E.G. Curry Research Fund
Albert Edward Rostern Mesothelioma Research
Fund
Ann Rom Research Fund
Barbara Sharpless Breast Cancer Research Fund
Barrick Gold Corporation Prostate Research Fund
Bartley Bull Clinical Research Fund
Beatty Biological Research Fund
Bulhoes Head and Neck Fund
C. Victor Secrett Research Fund
Carolyn Budovitch Brain Tumour Research
Endowment Fund
Catherine M. Wanless Research Fund
Charles Krowitz Endowment Fund for Burkitt’s
Lymphoma Research
Cohen and Morrison Pathology Research Fund
Dalia McKiee Endowment Fund
Deirdre Clement Research Fund
Dong Luong Huynh Research Fund
Donna Steinberg Lung Cancer Research Fund
Dorothy Gordon Buck Endowment Fund
Dr. Jane Poulson Breast Cancer Research Fund
Dr. Joseph K. McConnon Fund
Eckler Research Endowment Fund
Edie and Eric Yolles Research Fund
Edward E. Wise Research Fund
Edward Futerman Leukemia Research Fund
Eleanor and Burnett Thall Research Fund
Elizabeth Duke Research Fund
Elma Pearl Pinder Research Fund
Enid Hildebrand Cancer Research Fund
Ernest A. and Evelyn C. Byworth Trust for Research
Fund
Fielding Family Research Fund
Florence Winberg Endowment Fund
Freda Ariella Muscovitch Ovarian Cancer Research
Fund
Gail Eisen Pancreatic Cancer Research Fund
George and Kathleen Vice Research Fund
Gerry and Nancy Pencer Brain Tumour Centre
Endowment Fund
Gibson Clinical Research Fund
Girling/MacLellan Research Fund
Glenn and Marilyn Hunnings Fund in Haemopoiesis/
Lymphopoiesis Research
Guthrie Family Fund
Gwendolyn H. Riding Research Fund
Harley Ulster and Cindy Leder Multiple Myeloma
Fund
Harold E. Yeo Research Fund
Harry and Eleanor O’Neill Research Fund
Helen V. Crawford Research Fund
Honourable Willard Z. Estey Fund
Hubert B. Sceats Research Fund
JCB Grant Cancer Research Fund
Jean E. McCulloch Research Fund
Jean E. Smith Research Fund
Joanna Lai Fund
John and Esther Loewen Family Fund
John Purkis Fund for Lung Cancer Research
Joseph Lorne Garvin Research Fund
Joseph Robert Russell Research Fund
Katharine S. McLeod Research Fund
Khurshed Sanjana Multiple Myeloma Research Fund
Lee K. and Margaret Lau Breast Cancer Research
Fund
Leslie Zeev Mozes Fund
Lyndsay, Joey and Sam Lyons Fund
M. Ann MacMillan Research Fund
Margaret Mary Vivian Endowment Fund
Margaret Pollard Research Fund
Marion H. McRobert Research Fund
Mary C. Conway Research Fund
Mary Pawlyk Fund for Research into Genitourinary
Malignancies
Mary Pawlyk Fund for Research into Lung Cancer
McDowell-Silcox Family Research Fund
Melissa Ann Katzman Cancer Research Fund
Mildred Eady Research Fund
Mindy Kirsh Endowment Fund
Nizar and Gulzar Kanji Fund
Norman Latowsky Leukemia Fund
Pak Heng Chu Research Fund
Paola Colozza Fund for Drug Discovery
Paul MacDonald Fund
Pearl Banks Family Endowment in Melanoma
Research and Patient Care Fund
Philip and Terry Browman Ovarian Cancer Research
Fund
Philip Lavorgna Life Over Lymphoma Endowment
Fund
Philip Torno Cancer Research Endowment Fund
Reid-Weston Family Leukemia Research Fund
Roy Arthur Fawcett Cancer Research Fund
Ryder MacDougall Family Fund
Shiraz Bagli Memorial Fund for Basic Research in
Ovarian Cancer
Shirley Mak Breast Cancer Research Fund
Spooner Family Endowment Fund
Susan E. Crerar Ovarian Cancer Early Detection
Fund
Sylvia Jaychuk Pancreatic Cancer Research Fund
TD Fund for Medical Discovery
Teddy Orenstein Research Fund
Tehmi Boman Shroff Fund in Multiple Myeloma
Research
Terry Watson Research Fund
Thoracic Oncology Lab Fund
Tony Pennella Fund
Val Trypuc Sarcoma Research Fund
Valerie Dickson Fund
W.J. Collins and J.A. McNab Research Fund
Walter B. Pape Fund
Westaway Chair in Ovarian Cancer Research Fund
William and Dorothy Drevnig and Family Ovarian
Cancer Research Fund
Patient Care, Education and Other
Funds
Ask Ethel Fund
Dr. Joseph Neil Monteith Dunsmore Fund
Gladys M. Davis Patient Services Fund
John L. Hickey Endowment Fund
John Russell Koshan Hibiscus Fund for Hope
Junior League of Toronto Pediatric Radiation Fund
Lynn King Palliative Care Fund
Max Tanenbaum Music Program Fund
Monica Wright Roberts National Breast Cancer
Endowment Fund
Morris and Marcia Kwinter Fund
Morrissey-Copping Palliative Care Endowment Fund
Pencer Centre Patient and Family Advisory
Committee Fund
Phyllis Smith Nursing Education Fund
Robert Visagie Bone Marrow Transplant Fund
Shawn’s Miracle Fund
Sylvia and Louis Lockshin Patient Education Program
Fund
Vera McDermott Patient Education Fund
31
Research Chairs
An endowed Chair is the highest honour in academic life, prestigious for Chairholder and donor alike. Princess
Margaret Hospital is committed to fostering academic excellence and each endowed Chair enhances our ability to
attract and retain leading researchers, educators and trainees. Our Chairholders are recognized internationally for
superior academic achievement, experience and success in teaching and research.
Chair
Chairholder
The AMGEN Chair in Cancer Research
The Bartley-Smith/Wharton Chair in Radiation Oncology
The Daniel E. Bergsagel Chair in Medical Oncology
Molly and David Bloom Chair in Multiple Myeloma Research
Alan B. Brown Chair in Molecular Genomics
The Ronald N. Buick Chair in Cancer Research
Butterfield/Drew Chair in Breast Cancer Survivorship
M. Qasim Choksi Chair in Lung Cancer Translational Research
J. Douglas Crashley Chair in Gynecologic Cancer Research
Dr. Mariano A. Elia Chair in Head & Neck Cancer Research
Anna-Liisa Farquharson Chair in Kidney Cancer Research
The Orey and Mary Fidani Family Chair in Radiation Physics
Gattuso Chair in Breast Surgical Oncology
The JCB Grant Chair in Oncologic Pathology
The K.Y. Ho Chair in Prostate Cancer Research
The Alan and Susan Hudson Chair in Neuro-Oncology
Kirchmann Family Chair in Neuro-Oncology Research
Lee K. and Margaret Lau Chair in Breast Cancer Research
The Harold and Shirley Lederman Chair in Palliative Care
The Love Chair in Prostate Cancer Prevention Research
The Addie MacNaughton Chair in Thoracic Radiation Oncology
The Philip S. Orsino Chair in Leukemia Research
OSI Pharmaceuticals Foundation Chair in Cancer New Drug Development
RBC Financial Group Chair in Oncology Nursing Research
Kevin and Sandra Sullivan Chair in Surgical Oncology
Joey and Toby Tanenbaum/Brazilian Ball Chair
The Scott Taylor Chair in Lung Cancer Research
Weekend to End Breast Cancer Chair in Breast Cancer Research
The Robert E. Wharton Chair in Head & Neck Surgery
The Robert E. Wharton Chair in Reconstructive Plastic Surgery
Dr. Robert Rottapel
Dr. Brian O’Sullivan
Dr. Ian Tannock
To be appointed
Dr. Geoffrey Liu
Dr. Chris Paige
Dr. Pamela Catton
Dr. Ming Tsao
Dr. Joan Murphy
Dr. Fei-Fei Liu
Dr. Michael Jewett
Dr. David Jaffray
Dr. David McCready
To be appointed
Dr. Malcolm Moore
Dr. Abhijit Guha
Dr. Warren Mason
Dr. Senthil Muthuswamy
Dr. Gary Rodin
Dr. Neil Fleshner
Dr. Andrea Bezjak
Dr. Mark Minden
To be appointed
Dr. Doris Howell
Dr. Jonathan Irish
Dr. Gang Zheng
Dr. Frances Shepherd
Dr. Tak Mak
Dr. Pat Gullane
Dr. Stefan Hofer
PMH-held Chairs at University Health Network
The Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation
The Fleck/Tanenbaum Chair in Prostatic Diseases
Scott/Whitmore Chair in Hematology & Gene Therapy
Dr. Armand Keating
Dr. John Trachtenberg
To be appointed
Awards of Distinction
Dr. Tak Mak
2009 inductee to Canadian
Medical Hall of Fame
Dr. Brad Wouters
Michael Fry Radiation Research Award
Dr. Geoffrey Liu
2008 William E. Rawls Prize
32
New Chair Appointments
The Kirchmann Family Chair in Neuro-Oncology Research
Dr. Warren Mason is the medical director of Princess Margaret’s multidisciplinary treatment centre
for brain tumours—the largest centre for this purpose in Canada. In addition to his clinical and
research activities at The Princess Margaret, he is also the chair of the brain disease site of the
National Cancer Institute of Canada Clinical Trials Group.
Dr. Mason graduated in medicine from the University of Toronto, and completed residences in
Internal Medicine and Neurology at the University of Toronto and McGill University. He received
fellowship training in neuro-oncology at Memorial Sloan-Kettering Cancer Center in New York.
The focus of Dr. Mason’s current research is the development of medical therapies for primary brain tumours.
The Kevin and Sandra Sullivan Chair in Surgical Oncology
Dr. Jonathan Irish is the Chief of Surgical Oncology for PMH, Head of Surgical Oncology for
Cancer Care Ontario and Professor of Otolaryngology-Head and Neck Surgery at the University
of Toronto. He is a multi-talented leader and mentor at the hospital focusing on head and neck
oncology and surgical reconstruction of the head and neck region. He completed his residency
training at UCLA and the University of Toronto.
Current research priorities for Dr. Irish include the emerging Guided Therapy Program (GTx)
that will be the immediate focus for the Kevin and Sandra Sullivan Chair in Surgical Oncology.
New image-guided technology is being installed and tested in the surgical oncology operating
theatres of University Health Network, and this equipment holds great promise for sparing more healthy tissue in the
removal of tumours leading to quicker recovery.
The Love Chair in Prostate Cancer Prevention Research
Dr. Neil Fleshner is Head of the Genitourinary Cancer Site Group for PMH and Associate Professor at
the University of Toronto. He is an exceptional surgeon and clinical scientist, and his practice focuses
on the prevention and surgical treatment of urologic malignancy, with an emphasis on prostate
cancer. Dr. Fleshner earned his MPH degree from the School of Public Health at Columbia University,
and completed his oncology training at Memorial Sloan-Kettering Cancer Center in New York.
Dr. Fleshner oversees a basic science research laboratory and is conducting two randomized trials
testing the efficacy of micronutrients in preventing prostate cancer.
The Molly and David Bloom Chair in Multiple Myeloma Research
Molly and David Bloom have donated $1 million to establish the Molly and David Bloom Chair in Multiple
Myeloma Research. Every day 7 more Canadians are diagnosed with multiple myeloma, an incurable blood
cancer. This Chair will lead research into better screening and early detection methods, and help move promising
new drugs from the laboratory to needy patients as quickly as possible.
A search is currently being conducted, and an appointment for this Chair is expected to be announced in the
fall of 2009.
33
Financials
March 31, 2009
The accompanying financial statements of The Princess Margaret Hospital Foundation were prepared by management in accordance with generally accepted accounting principles.
Management is responsible for the integrity and objectivity of the financial statements and has established systems of
internal control which are designed to provide reasonable assurance that assets are safeguarded from loss or unauthorized use and to produce reliable accounting records for the preparation of financial information.
The Board of Directors is responsible for ensuring that management fulfills its responsibility for financial reporting and
internal control. The Board exercises its responsibilities through the Investment Committee, composed of members
of the Board, who meet regularly with representatives of management and with the external investment managers
and consultants, to monitor the performance of the investment portfolio. The Audit & Accountability Committee
comprised of members of the Board and the community, meets regularly with management to monitor the financial
activity of the Foundation together with the functioning of the accounting and control systems. This Committee also
meets with management and the external auditors to review the results of the auditing activity.
The external auditors have conducted an independent audit, in accordance with generally accepted standards, and
have expressed their opinions on the financial statements. Their report outlines the nature of their audit and their
opinion on the fairness of the financial statements of The Princess Margaret Hospital Foundation and the accounting
principles followed in management’s preparation thereof.
Chairman, Board of Directors
Paul Alofs
President & CEO
John H. Bowey, FCA
Chair, Audit &
Accountability Committee
Asha Raheja, CMA
Treasurer
34
AUDITORS' REPORT
To the Members of
We have audited the balance sheet of The Princess Margaret Hospital
Foundation as at March 31, 2009 and the statement of revenue, expenses and
changes in fund balances for the year then ended. These financial statements are
the responsibility of the Foundation's management. Our responsibility is to
express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with Canadian generally accepted auditing
standards. Those standards require that we plan and perform an audit to obtain
reasonable assurance whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
In our opinion, these financial statements present fairly, in all material respects,
the financial position of the Foundation as at March 31, 2009 and the results of its
operations and its cash flows for the year then ended in accordance with Canadian
generally accepted accounting principles.
As required by the Canada
Corporations Act, we report that, in our opinion, these principles have been
applied on a basis consistent with that of the preceding year.
Toronto, Canada,
May 29, 2009.
Incorporated under the laws of Canada
BALANCE SHEET
As at March 31
2009
$
ASSETS
Cash [note 3]
Accounts receivable
Deferred expenses [notes 9, 10 and 12]
Investments, at market [note 4]
Capital assets, net [note 5]
LIABILITIES AND FUND BALANCES
Liabilities
Due to University Health Network [note 15]
Accounts payable
Deferred revenue [notes 9, 10 and 12]
Total liabilities
Fund balances
General Fund
Restricted Fund [note 6]
Endowment Fund [note 7]
Total fund balances
$
43,311
683
6,885
216,504
98
267,481
43,714
75
8,297
239,500
156
291,742
18,476
1,229
16,261
35,966
17,350
1,224
26,940
45,514
4,187
137,746
89,582
231,515
267,481
3,165
133,945
109,118
246,228
291,742
Commitments and contingencies [note 16]
See accompanying notes
On behalf of the Board:
Director
2008
[000's]
Director
STATEMENT OF REVENUE, EXPENSES AND CHANGES IN FUND BALANCES
Year ended March 31
General Fund
2009
2008
$
REVENUE
Fundraising, net [note 8]
Strategic events, net [notes 9 and 10]
Lotteries, net [note 12]
Other [note 11]
Investment income (loss) [note 13]
EXPENSES
Fundraising and administrative [note 15]
Excess (deficiency) of revenue over expenses before grants
Grants
Ontario Cancer Institute/Princess Margaret Hospital
[notes 11[a] and 15]
Excess (deficiency) of revenue over expenses for the year
Fund balances, beginning of year
Interfund transfers [note 14]
Fund balances, end of year
See accompanying notes
[000's]
Restricted Fund
2009
2008
[000's]
$
Endowment Fund
2009
2008
$
[000's]
$
Total
2009
$
4,185
312
⎯
150
4,647
(753)
3,894
5,059
—
—
⎯
5,059
4,245
9,304
30,369
18,430
15,587
⎯
64,386
613
64,999
28,564
12,966
13,714
⎯
55,244
2,642
57,886
4,117
⎯
⎯
⎯
4,117
(18,327)
(14,210)
6,187
—
—
⎯
6,187
(415)
5,772
38,671
18,742
15,587
150
73,150
(18,467)
54,683
39,810
12,966
13,714
⎯
66,490
6,472
72,962
6,285
(2,391)
6,188
3,116
1,007
63,992
503
57,383
⎯
(14,210)
—
5,772
7,292
47,391
6,691
66,271
267
(2,658)
—
3,116
61,683
2,309
54,637
2,746
154
(14,364)
—
5,772
62,104
(14,713)
54,637
11,634
3,165
3,680
4,187
1,286
(1,237)
3,165
133,945
1,492
137,746
125,800
5,399
133,945
109,118
(5,172)
89,582
246,228
⎯
231,515
234,594
—
246,228
107,508
(4,162)
109,118
$
2008
$
[000's]
$
NOTES TO FINANCIAL STATEMENTS
[in thousands]
March 31, 2009
1. PURPOSE OF THE ORGANIZATION
The Princess Margaret Hospital Foundation [the "Foundation"] is incorporated under the Canada
Corporations Act. The Foundation was established to solicit, receive and maintain funds and to
apply these funds to improve and enhance cancer research, professional education and patient care
activities provided by the Ontario Cancer Institute/Princess Margaret Hospital ["OCI/PMH"],
which are part of the University Health Network ["UHN"].
The Foundation is a public foundation registered under the Income Tax Act (Canada) [the "Act"]
and, as such, is exempt from income taxes and able to issue donation receipts for income tax
purposes, under Registration Number 88900 7597 RR 0001.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The financial statements of the Foundation have been prepared in accordance with Canadian
generally accepted accounting principles. The following summary of significant accounting
policies is set forth to facilitate the understanding of these financial statements:
Fund accounting
In order to ensure observance of the limitations and restrictions placed on the use of resources
available to the Foundation, the accounts of the Foundation are maintained in accordance with the
principles of fund accounting. Accordingly, resources are classified for accounting and reporting
purposes into funds. These funds are held in accordance with the objectives specified by the
donors or in accordance with directives issued by the Board of Directors [the "Board"]. Transfers
between the funds are made when it is considered appropriate and authorized by the Board. To
meet these objectives of financial reporting and stewardship over assets, certain interfund transfers
are necessary to ensure the appropriate allocation of assets and liabilities to the respective funds.
These interfund transfers are recorded in the statement of revenue, expenses and changes in fund
balances.
[in thousands]
March 31, 2009
For financial reporting purposes, the accounts have been classified into the following funds:
[a] General Fund
The General Fund accounts for the Foundation's general fundraising, granting and
administrative activities. The General Fund reports unrestricted resources available for
immediate purposes.
[b] Restricted Fund
The Restricted Fund includes those funds where resources are to be used for an identified
purpose as specified by the donor, as stipulated by the fundraising appeal or as determined by
the Board.
[c] Endowment Fund
The Endowment Fund includes those funds where either donor or internal restrictions require
that the principal be maintained by the Foundation on a permanent basis.
Investments and investment income
The investments of the Foundation are recorded at market value. Publicly traded securities are
valued based on the latest bid prices. Pooled funds and other investments that are not publicly
traded are valued based on values reported by the external investment manager. Short-term
securities are valued based on cost plus accrued income, which approximates fair value.
Transactions are recorded on a settlement date basis and transaction costs are expensed as
incurred. Investment income, which consists of dividends, interest, distributions from pooled
funds, realized and unrealized gains and losses, is recorded as revenue in the statement of revenue,
expenses and changes in fund balances.
Investment income earned on Endowment Fund or Restricted Fund resources that must be spent
on donor-restricted activities is recognized as revenue of the Restricted Fund. Investment income
subject to donor restrictions stipulating that it be added to the principal amount of the endowment
is recognized as revenue of the Endowment Fund. Unrestricted investment income earned on
Endowment Fund, Restricted Fund and General Fund resources is recognized as revenue of the
General Fund.
Derivative financial instruments are marked to market, with gains and losses recognized in income
in the year in which the changes in market value occur.
[in thousands]
March 31, 2009
Foreign currency translation
Revenue and expenses denominated in foreign currencies are translated into Canadian dollars at
the transaction date. Investments and other monetary items denominated in foreign currencies are
translated at the year-end rate.
Revenue recognition
Donations are recorded on a cash basis since pledges are not legally enforceable claims.
Donor-restricted donations for endowment purposes are recognized as revenue in the Endowment
Fund. Other donor-restricted donations are recognized as revenue of the Restricted Fund.
Unrestricted donations are recognized as revenue of the General Fund.
Lottery, Weekend to End Breast Cancer and other events revenue are recognized net of all related
expenses in the fiscal year in which the program is concluded. Revenue and expenses related to
lotteries for which prize draws take place and events that take place subsequent to the year end are
deferred.
Grant recognition
Grants are recognized when payable.
Contributed goods and services
Contributed capital assets that are transferred to UHN are recognized at their fair market value in
the financial statements. Other contributed goods and services are not recognized.
Capital assets
Purchased capital assets are recorded at cost. Donated capital assets are recorded at fair value at
the date of contribution.
Amortization is provided on a straight-line basis over the estimated useful lives of the assets as
follows:
Office equipment
Computer hardware and software
10 years
3 years
[in thousands]
March 31, 2009
Financial instruments
The Foundation is subject to market, currency and interest rate price risks with respect to its
investments. To manage these risks, the Foundation has established a target mix of investment
types designated to achieve the optimum return with reasonable risk tolerance.
The Foundation has chosen to apply CICA 3861: Financial Instruments - Disclosure and
Presentation in place of CICA 3862: Financial Instruments - Disclosures and CICA 3863:
Financial Instruments - Presentation.
Employee future benefit plans
The Foundation participates in a multi-employer defined benefit pension plan and a non-pension
defined benefit plan sponsored by UHN. Contributions to these plans are expensed when due.
Use of estimates
The preparation of financial statements in conformity with Canadian generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at
the date of the financial statements and the reported amounts of revenue and expenses during the
reporting period. Actual results could differ from those estimates.
Changes in accounting policies
Effective April 1, 2008, the Foundation adopted the recommendations of CICA 1535: Capital
Disclosures, which require the disclosure of qualitative and quantitative information that enables
users of the financial statements to evaluate the Foundation's objectives, policies and processes for
managing capital. The adoption of these recommendations only required additional disclosures
which are provided in note 19.
Effective April 1, 2008, the Foundation adopted retroactively the changes to the recommendations
in CICA 4400: Financial Statement Presentation for Not-For-Profit Organizations that eliminate
the requirement to separately disclose the amount of fund balances invested in capital assets, that
were previously disclosed as a component of the General Fund. The Foundation has therefore
eliminated from the financial statements details about the amount of fund balances invested in
capital assets that were previously disclosed as a component of the General Fund and the
calculation of this amount.
[in thousands]
March 31, 2009
Future changes in accounting policies
The CICA has issued revisions to the 4400 series and certain other sections to amend or improve
certain parts of the CICA Handbook that relate to not-for-profit organizations. With respect to
presentation, these changes include making the disclosure of fund balances invested in capital
assets optional, making CICA 1540: Cash Flow Statements applicable to not-for-profit
organizations; and requiring the reporting of revenues and expenses on a gross basis in the
statement of operations unless not required by other guidance. A new section, CICA 4470:
Disclosure of Allocated Expenses by Not-for-Profit Organizations, was included in the revisions
which requires certain disclosures when fundraising and general support expenses are allocated to
other functions. These changes in accounting policies must be adopted by years beginning on or
after January 1, 2009 with earlier adoption permitted.
Management has adopted the
recommendations related to the disclosure of fund balances invested in capital assets and is
assessing the impact of the other revisions. However, the impact will be limited to reclassification
of numbers in the statements and additional disclosures.
In February 2008, the Accounting Standards Board amended CICA 1000: Financial Statement
Concepts to clarify that assets not meeting the definition of an asset or the recognition criteria are
not permitted to be recognized on the balance sheet. The amendments are effective for financial
statements for fiscal years beginning on or after October 1, 2008. The Foundation is examining its
current approach to recognizing costs as assets and will implement these standards effective
April 1, 2009 retroactively with restatement of the prior year. The impact of implementing these
amendments on the financial statements is currently not known.
3. CASH
Cash consists primarily of amounts held for the Restricted Fund and net funds received in advance
related to lotteries and events to be held during the next fiscal year.
[in thousands]
March 31, 2009
4. INVESTMENTS
[a] Investments consist of the following:
Cash
Short-term investments
Bonds
Canada/Provincial
Corporate
Pooled funds
Canadian
Global
Equities
Canadian
U.S. and other foreign
Alternative investments
Forward foreign exchange contracts
2009
2008
$
$
13,959
4,793
9,977
3,312
23,997
90,472
23,903
89,026
19,348
3,603
137,420
6,518
⎯
119,447
8,270
25,770
34,040
29,110
(2,818)
216,504
23,818
29,126
52,944
53,820
⎯
239,500
Alternative investments include investments in hedge funds and private capital. The amounts
invested in pooled funds have been allocated among the asset classes, based on the asset
classes held by the pooled funds.
In order to manage foreign currency exposure, the Foundation has entered into a forward
foreign exchange contract. At March 31, 2009, one contract with a US bank allows the
Foundation to sell US $40 million on April 6, 2009 at an exchange rate of 1.1887. The fair
market value of this contract as at March 31, 2009 is a loss of $2,818.
[b] Investments are managed as two pools:
•
Investments related to the Endowment Fund are invested as follows: short-term
investments – 11% [2008 - 1%], bonds – 20% [2008 - nil], equities – 40% [2008 - 50%],
alternative investments – 29% [2008 – 49%]. During the year, the Foundation reallocated
the investments held for endowments to reflect the revised asset mix included in the
updated Statement of Investment Policies and Goals.
[in thousands]
March 31, 2009
•
Investments related to the General and Restricted Funds are substantially invested in
short-term investments and bonds. The fixed income securities in the general and
restricted portfolio had a weighted average yield of 7.87% [2008 - 5.27%] and an average
term to maturity of 8.9 years [2008 - 8.5 years].
[c] The Foundation has made a commitment to invest $18,000 in private capital over the next 3
to 5 years.
5. CAPITAL ASSETS
Capital assets consist of the following:
2008
2009
Office equipment
Computer hardware
and software
Cost
Accumulated
amortization
Net
book
value
$
$
$
Cost
Accumulated
amortization
Net
book
value
$
$
$
230
165
65
230
147
83
317
547
284
449
33
98
309
539
236
383
73
156
Amortization expense recorded in the accounts is $66 [2008 - $98]. Capital asset purchases were
$8 [2008 - $82].
[in thousands]
March 31, 2009
6. RESTRICTED FUND
The Restricted Fund consists of funds available for spending that are restricted by donors or the
Board for the following purposes:
Donor-restricted balances
Restricted for research purposes
Restricted for purchase of capital assets
Restricted for patient support and other
Internally imposed restrictions
Restricted for research purposes
Other
2009
2008
$
$
98,202
10,940
26,182
135,324
102,944
8,214
20,682
131,840
2,287
135
2,422
137,746
1,942
163
2,105
133,945
7. ENDOWMENT FUND
The Endowment Fund consists of externally restricted contributions received by the Foundation
where the endowment principal is required to be maintained intact. The Endowment Fund also
includes internal resources transferred by the Board to the Endowment Fund, with the intention
that the principal be maintained intact. The investment income generated from assets held for
endowment purposes must be used in accordance with the various purposes established by the
donors or the Board.
[in thousands]
March 31, 2009
Major categories of restrictions on fund balances are as follows:
Externally imposed endowments
Endowments, the income from which must
be used for research purposes
Endowments, the income from which must
be used for other restricted purposes
Internally imposed endowments approved by the Board
Funds restricted for research
Funds restricted for other purposes
Unrestricted funds
2009
2008
$
$
64,361
79,295
11,039
75,400
12,783
92,078
7,379
590
6,213
14,182
89,582
9,767
784
6,489
17,040
109,118
8. FUNDRAISING
General Fund
2009
2008
Fundraising revenue
Annual programs
Major gifts and bequests
Less direct program costs
Net fundraising
$
$
3,729
1,743
5,472
1,287
4,185
3,404
2,389
5,793
734
5,059
Restricted Fund Endowment Fund
2009
2008
2009
2008
$
12,515
22,238
34,753
4,384
30,369
$
10,981
21,302
32,283
3,719
28,564
$
$
221
3,896
4,117
⎯
4,117
296
5,891
6,187
—
6,187
[in thousands]
March 31, 2009
9. WEEKEND TO END BREAST CANCER
During the year, the Foundation held a fundraising event, the Weekend to End Breast Cancer.
Financial results included in strategic events on the statement of revenue, expenses and changes in
fund balances are as follows:
Revenue
Expenses
Logistics
Marketing and other
2009
2008
$
$
13,499
17,415
3,245
1,193
4,438
9,061
3,277
1,172
4,449
12,966
As at March 31, 2009, costs of $1,010 [2008 - $1,066] incurred and revenue of $1,603 [2008 $1,859] received during the year ended March 31, 2009 associated with the event to be held in
September 2009 have been deferred and recorded in the balance sheet. The results of the event
will be recorded as revenue and expenses in the financial statements for the year ending March 31,
2010.
10. RIDE TO CONQUER CANCER
During the year, the Foundation held a new fundraising event, the Ride to Conquer Cancer.
Financial results included in strategic events on the statement of revenue, expenses and changes in
fund balances are as follows:
Revenue
Expenses
Logistics
Marketing and other
2009
2008
$
$
14,814
⎯
3,154
1,979
5,133
9,681
⎯
⎯
⎯
⎯
[in thousands]
March 31, 2009
As at March 31, 2009, costs of $1,920 [2008 - $2,117] incurred and revenue of $4,504 [2008 $4,668] received during the year ended March 31, 2009 associated with the event to be held in
September 2009 have been deferred and recorded in the balance sheet. The results of the event
will be recorded as revenue and expense in the financial statements for the year ending March 31,
2010.
11. BRAZILIAN BALL AND PROVINCIAL GRANT
[a] The Foundation was the beneficiary of the Brazilian Ball [the "Ball"] held May 24, 2008. In
addition to the net proceeds from the gala, as part of the Brazilian Ball campaign, the
Foundation raised additional amounts for nursing programs and research at the Campbell
Family Centre Research Institute. Net proceeds from the gala, details of which are set out
below, and pledges, some of which will be recorded in the future, which total approximately
$7,000, were received.
In addition, a grant of $15,000 was announced by the Province of Ontario to support The
Anna Maria de Souza Knowledge Transfer Centre for Oncology Nursing [the "Centre"].
Since the Foundation is acting as a paymaster for this grant, the Province of Ontario will pay
the Foundation $3,000 per year over 5 years. In fiscal 2009, the first payment of $3,000 was
received and $2,850 was paid to the University Health Network who, jointly with Cancer
Care Ontario, is administrating the grant. An amount of $150 was recorded as other revenue
in the General Fund representing the Foundation's fee.
[b] Financial results of the Ball included in fundraising revenue on the statement of revenue,
expenses and changes in fund balances are as follows:
Revenue
Expenses
2009
$
2008
$
3,208
2,124
1,084
⎯
⎯
⎯
[in thousands]
March 31, 2009
[c] Included in the gross revenue and expenses of the Ball are the net proceeds of a fund raising
raffle [Lottery License PMH0642 issued by the Alcohol and Gaming Commission of
Ontario], the details of which are as follows:
Gross proceeds
Expenses
Net proceeds
2009
2008
$
$
90
4
86
⎯
⎯
⎯
12. LOTTERIES
During the year ended March 31, 2009, the Foundation held 2 lotteries [2008 - three lotteries].
Financial results are as follows:
Revenue
Expenses
Prizes
Marketing and other
2009
2008
$
$
56,897
66,632
21,797
19,513
41,310
15,587
28,433
24,485
52,918
13,714
Prior to March 31, 2009, the Foundation committed to carrying out the spring 2009
Princess Margaret Hospital Home Lottery [the "Home Lottery"], which was held in May 2009. As
at March 31, 2009, costs of $3,819 [2008 - $4,322] incurred and revenue of $9,648 [2008 $18,255] received during the year ended March 31, 2009 associated with the Home Lottery have
been deferred and recorded in the balance sheet. The results of the Home Lottery will be recorded
as revenue and expense in the financial statements for the year ending March 31, 2010. The
Foundation has a standby letter of credit of $12,954 that expires on July 13, 2009 obtained in
connection with the Home Lottery.
[in thousands]
March 31, 2009
13. INVESTMENT INCOME (LOSS)
[a] Investment income (loss) earned on the Foundation's assets consists of the following:
Interest and dividends
Realized gains (losses)
Net change in unrealized loss on investments
Less investment management and custodial fees
2009
2008
$
$
10,662
(7,414)
(21,274)
(18,026)
441
(18,467)
14,871
1,293
(8,757)
7,407
935
6,472
[b] Investment income is allocated among the funds based on the Foundation's capital
preservation policy. This policy has the objective of protecting the real value of the
endowments by limiting the amount of earned income available for spending and requiring
the reinvestment of any income earned in excess of this limit. This preservation of capital is
recorded as revenue of the Endowment Fund for externally endowed funds. For internally
endowed funds, the preservation of capital is recorded as income of the General Fund and
transferred to the Endowment Fund in the statement of revenue, expenses and changes in fund
balances. In any year, should net investment income not be sufficient to fund the amount
required for spending, the amount that is to be made available for spending is funded by a
transfer from the Endowment Fund.
Currently, the income available for spending is set at 4% of the market value of the
Endowment Fund balances. An additional 1% is recorded in the General Fund to cover
administrative costs.
Investment income recorded in the Restricted Fund represents income earned on endowments
where the donor has stipulated that the income must be used for restricted purposes or where
there are agreements requiring income to be allocated to restricted funds.
[c] Gains and losses arising from the sale of donated investments that fund specific endowed or
restricted funds are recorded in these funds.
[d] In 2009, investments held for endowments incurred an investment loss of $18,327. As a
result, no investment income was available for preservation of capital, to make available for
spending or to cover administrative costs. With respect to externally endowed funds, the
funds available for spending of $3,724 were transferred from the Endowment Fund to the
Restricted Fund and the amount available to cover administrative costs of $931 was
[in thousands]
March 31, 2009
transferred from the Endowment Fund to the General Fund. With respect to internally
endowed funds, the funds available for spending of $694 were transferred from the
Endowment Fund to the Restricted Fund. The amount available to cover administrative
expense of $173 was transferred from the Endowment Fund to the General Fund and $3,438
to cover investment losses was transferred from the Endowment Fund to the General Fund.
In 2008, investments held for endowments incurred an investment loss of $415. As a result,
no investment income was available for preservation of capital, to make available for
spending or to cover administrative costs. With respect to externally endowed funds, the
funds available for spending of $4,555 were transferred from the Endowment Fund to the
Restricted Fund and the amount available to cover administrative costs of $910 was
transferred from the Endowment Fund to the General Fund. With respect to internally
endowed funds, the shortfall of funds available for spending of $810 was transferred from the
Endowment Fund to the Restricted Fund and the amount available to cover administrative
costs of $233 was transferred from the Endowment Fund to the General Fund.
[e] In 2009, the Board approved transfers totalling $862 from the General Fund to the
Endowment Fund and $2,926 from the Restricted Fund to the Endowment Fund. The transfers
relate to internally endowed bequests and changes in the designation of funds as directed by
donors or the Board.
In 2008, the Board approved transfers totalling $2,346 from the General Fund to the
Endowment Fund and $34 to the Restricted Fund. These transfers relate to internally
endowed bequests and changes in the designation of funds as directed by donors or the Board.
14. INTERFUND TRANSFERS
Transfers between funds consist of the following:
General Fund
2009
2008
$
Board and donor approved
re: fund restrictions [note 13[e]] (862)
Allocation of investment
income in accordance
with Board policy [note 13[d]] 4,542
3,680
2009
2008
2009
2008
$
$
(2,380)
(2,926)
1,143
(1,237)
4,418
1,492
$
34
5,365
5,399
$
$
3,788
2,346
(8,960)
(5,172)
(6,508)
(4,162)
[in thousands]
March 31, 2009
15. RELATED PARTY TRANSACTIONS
[a] During the year, the Foundation funded the following projects carried out at the OCI/PMH
and UHN:
General Fund
2009
2008
$
Equipment
Research
Construction of centres
within the hospital
2009
2008
2009
2008
$
$
$
$
$
7
260
—
—
8,243
50,651
2,984
48,139
⎯
154
⎯
⎯
⎯
267
—
—
2,789
61,683
3,514
54,637
⎯
154
⎯
⎯
[b] UHN provides certain services to the Foundation and pays some expenses on behalf of the
Foundation. The Foundation reimburses UHN for all direct costs associated with services
provided and expenses paid. Administrative expenses include a charge of $104 [2008 - $102]
paid to UHN for office space and service fees.
[c] The Foundation pays certain common expenses on behalf of affiliated foundations and is
reimbursed for these expenses. In addition, the Foundation reimburses affiliated foundations
for those common expenses incurred by these foundations on behalf of the Foundation.
[d] Salaries, benefits and certain other expenses are paid by UHN and are reimbursed by the
Foundation.
[e] Amounts due to UHN are non-interest bearing and due on demand. Transactions between
UHN and the Foundation are in the normal course of business and are measured at the
exchange amount, which is the amount of consideration established and agreed to by the
related parties.
16. COMMITMENTS AND CONTINGENCIES
[a] As at March 31, 2009, the Foundation approved plans to make a research grant of $18,000 to
OCI/PMH which will be expensed during the year ending March 31, 2010.
[b] The Foundation has received a claim for damages. The Foundation considers this claim to be
without merit and is defending it.
[in thousands]
March 31, 2009
17. UNIVERSITY OF TORONTO GRADUATE STUDENT ENDOWMENT
During 1997, the Foundation negotiated an agreement in which a grant of $3,300 from the
Foundation to the University of Toronto [the "University"] was matched equally by the
University and the Ontario Government through the Ontario Student Opportunity Trust Fund.
This established a $9,900 endowment to be held by the University for the benefit of graduate
students studying with University faculty members located at the hospital facilities and engaged in
cancer research.
The following financial results for the year ended April 30, 2009 were reported by the University
to the Foundation:
Endowment
Fund
$
Balance, at market value, as at April 30, 2008
Investment loss
Transfer to Expendable Fund
Student awards
Balance, at market value, as at April 30, 2009
12,830
(3,962)
⎯
⎯
8,868
Expendable
Fund
$
585
⎯
⎯
(231)
354
18. STATEMENT OF CASH FLOWS
A separate statement of cash flows has not been presented since cash flows from operating,
investing and financing activities are readily apparent from the other financial statements.
19. CAPITAL MANAGEMENT
In managing capital, the Foundation focuses on liquid resources available for operations. The
Foundation's objective is to have sufficient liquid resources to continue operating despite adverse
financial events and to provide it with the flexibility to take advantage of opportunities that will
advance its purposes. The need for sufficient liquid resources is considered in the preparation of
an annual budget and in the monitoring of cash flows and actual operating results compared to the
budget. As at March 31, 2009, the Foundation has met its objective of having sufficient liquid
resources to meet its current obligations.
Investment Management at The Princess Margaret
Hospital Foundation
A Report From the Foundation’s Investment Committee
The value of the Foundation’s investment portfolio stood at $217 million at the end of March 2009, compared to
$240 million at the end of March 2008. The calculated return on investments over the 12-month period was -9.4%.
While a negative return experience is never cause for celebration, it should be noted that over the same 12-month
period the Canadian stock market (S&P TSX) fell -32.4% and the US stock market (S&P 500) -41.0%.
There are two reasons why the Foundation’s investment portfolio came through the recent period of extreme capital
markets turmoil in relatively good condition. First, some years ago, the Investment Committee adopted a conservative investment policy. The policy recognized that a large portion of the payment obligations in support of cancer
research were medium-term in length, thus requiring the use of medium-term bonds rather than equities. The second
reason is that the Foundation employs investment experts to manage the bond and the more risk-taking components
of its investment portfolio.
The portfolio’s bond component is managed by Canso Investment Counsel and Jarislowsky Fraser, and the remainder
by Commonfund, a specialist organization in managing investment portfolios for educational and medical foundations. Our managers maintained adequate liquidity, and stayed clear of such troubled investments as asset-backed
commercial paper and complex ‘black box’ derivatives. However, as a measure of caution, the Foundation’s Board did
decide to reduce the payout on endowed funds from 5% to 4% this year. This policy will be reviewed again next year.
The decline in portfolio value would have been even more modest had the Canadian dollar not fallen significantly
against the US dollar over the 12-month period. The Foundation’s current policy is to hedge 50% of US dollar exposure above a US/CDN exchange rate of 90 cents, increasing to a 75% hedge below 90 cents. The rationale is that our
payment obligations are in Canadian dollars, and hence we need to control the amount of foreign exchange risk in
the portfolio. However, such a policy reduces returns during periods when the US dollar is strong versus the Canadian
dollar, as was the case over the March 2008 to March 2009 period. As we write this in early May, the Canadian dollar
is appreciating once again, re-enforcing the value of continuing to control foreign exchange risk. The Investment
Committee intends to review the Foundation’s foreign exchange hedging policy on a regular basis.
Looking ahead, financial markets have already staged a significant recovery from their March lows. It remains to be
seen if these gains can be sustained, or whether further turbulence lies ahead. Either way, the Foundation believes its
investment policy is appropriate for current conditions, and has confidence that it will continue to be expertly implemented by its investment managers.
54
Statement of Revenue and Expenses
2005
2006
2007
2008
2009
Net Revenue
Fundraising
27,584 31,134 36,485 39,810 38,671
Strategic events
10,891 12,187 13,246 12,966 18,742
Lotteries
19,906 18,581 15,270 13,714 15,587
Other
150
58,381 61,902 65,001 66,490 73,150
Investments
7,220 15,452 9,950 6,472 (18,467)
Total Net Revenue
65,601 77,354 74,951 72,962 54,683
Overhead Expenses
4,325 5,890 6,501 6,691 7,292
Overhead Expenses/Net Revenue*
6.6%
7.6%
8.7%
9.2%
13.3%
Net 61,276 71,464 68,450 66,271 47,391
Grants
Building
1,498 7,000 2,500 3,514 2,789
Research
27,712 35,483 43,942 47,439 50,365
Education
700 700 700 700 700
Equipment
2,368 2,399 7,373 2,984 8,250
Total Grants
32,278 45,582 54,515 54,637 62,104
Excess (def) of revenue
28,998 25,882 13,935 11,634 (14,713)
over expenses
Fund Balances
Endowments
87,302 101,292 107,508 109,118 Restricted
106,583 118,468 125,800 133,945 Unrestricted
892 899 1,286 3,165 194,777 220,659 234,594 246,228 Held By University of Toronto
11,553 12,797 14,057 13,415 Total Capital
206,330 233,456 248,651 259,643 * Net revenue includes Investment Return / (Loss)
Where our Revenue Comes From
Fundraising Strategic Events 89,582
137,746
4,187
231,515
9,222
240,737
How our Revenue is Used
Research
Building
Equipment
Education
Lotteries The Princess Margaret Hospital Foundation
55
56
The Princess Margaret Hospital Foundation (as of March 31, 2009)
Board of Directors
Board Committees
Neville W. Kirchmann – Chairman
(retired as of October 2, 2008)
Keith P. Ambachtsheer – Vice-Chair
(Chairman as of October 2, 2008)
Lloyd Atkinson
Dr. Robert Bell
John H. Bowey, FCA
David Butterfield
Tom Ehrlich
Stephen M. Goldhar
Dr. Mary Gospodarowicz
David P. Harris
Marianne Harris
Candace Innes
Chris Jordan
Nizar E. Kanji
Farsad Kiani
Dr. Benjamin Neel
Dr. Christopher J. Paige
Wendy C. Posluns
Jürgen Schreiber
Maureen Shaughnessy Kitts
Betsy Wright
Dr. Catherine Zahn
Audit and Accountability
Chair: John H. Bowey, FCA
Members:
Lloyd Atkinson
Terry Bacinello
Nizar E. Kanji
Officers
Paul Alofs
President & CEO
Asha Raheja
Treasurer
Breast Cancer
Chair: Maureen Shaughnessy Kitts
Members:
Dr. Robert Bell
David Butterfield
Dr. Pamela Catton
Dr. Mary Gospodarowicz
Carole Grafstein
Candace Innes
Farsad Kiani
Neville W. Kirchmann
Dr. Tak Mak
Dr. David McCready
Dr. Benjamin Neel
Dr. Christopher J. Paige
Governance
Chair: Betsy Wright
Members:
Nizar E. Kanji
Wendy C. Posluns
Dr. Catherine Zahn
Human Resources and
Compensation
Chair: David P. Harris
Members:
Dr. Robert Bell
Betsy Wright
Investment
Chair: Marianne Harris
Members:
Lloyd Atkinson
Stephen M. Goldhar
President & CEO’s Advisory
Committees
Major Gifts Committee
Chair: Lloyd Atkinson
Members:
David Butterfield
Tom Ehrlich
David P. Harris
Farsad Kiani
Neville W. Kirchmann
Lottery
Chair: Candace Innes
Members:
Chris Jordan
Maureen Shaughnessy Kitts
Margo C. Clarke
Secretary
Design: Y&R
Photography: Photographics Department, University Health Network; BDS Studios Inc.; Mike Cheliak Photography
Production: Corporate Graphics Department, University Health Network
Printing: Belbin & Associates, Toronto
OUR VISION
is to conquer cancer in our lifetime.
OUR CAUSE
is the patient.
OUR PARTNER
is the research hospital.
OUR DONORS
lead the way.
Office/Courier Address:
700 University Avenue, 8th Floor, Toronto, ON M5G 1Z5
Mailing Address:
610 University Avenue, Toronto, ON M5G 2M9
T: 416.946.6560 1.866.224.6560 F: 416.946.6563 www.pmhf.ca
Charitable Organization No. 88900 7597 RR0001
4

The Princess Margaret Hospital Foundation

Transcription

Similar documents

MCP 650 - Wavebid

Towards a more cost-effective Recruitment solution

Princess Margaret Annual Report

Annual Report 2008 - The Princess Margaret Hospital Foundation

Opportunities to solve the mass-hiring challenge

Aiko,the Princess of Love

Issue 23 - COX Comics

here - Landscape Architects

Developing and testing low cost LTD Stirling engines

to see who was at Fencex 2014

International Credentials

About Department - PG Admissions 2016

Big data Web sites: 40 billion indexed web pages Youtube: 100 hrs

wifi-soft solutions - Hotspot controller | Wireless Access Point

- Automechanika Johannesburg

Fall 2011 - Carpenters` District Council of Ontario

Terrestrial Ecosystem Mapping of the Southern Gulf

NEWSLETTER - Vinalhaven Public Library

St. Margaret Mary Parish

OfficeServ 7030 Installation Manual

Exotics - Princess Cruises

Q - ADMA-OPCO